BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 027788
(219 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 122 bits (307), Expect = 1e-28, Method: Compositional matrix adjust.
Identities = 60/154 (38%), Positives = 90/154 (58%), Gaps = 4/154 (2%)
Query: 24 GRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
GR+ +++ +G G+ K VY+ D E +EVAW +++ R +R E LK L
Sbjct: 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER--QRFKEEAEXLKGL 82
Query: 84 ANKNIISLHYVWRD--EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+ NI+ + W + + + +TE+ TSG L+ Y K+ + +K L+ W +QILKGL
Sbjct: 83 QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGL 142
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LHT P +IHRDL C N+F+ G TG VKIGDL
Sbjct: 143 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3 PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
P+ + DP + P + DP RY R LG G K Y D + EV +V
Sbjct: 17 PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59 KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
++ P E++ +E+ + K+L N +++ H + D+D + + E+C +L E
Sbjct: 75 VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K+ + V+ + + +Q ++G+ YLH + VIHRDL N+F+N + VKIGD
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3 PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
P+ + DP + P + DP RY R LG G K Y D + EV +V
Sbjct: 17 PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59 KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
++ P E++ +E+ + K+L N +++ H + D+D + + E+C +L E
Sbjct: 75 VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K+ + V+ + + +Q ++G+ YLH + VIHRDL N+F+N + VKIGD
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 75.5 bits (184), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 52/177 (29%), Positives = 88/177 (49%), Gaps = 11/177 (6%)
Query: 3 PAVNSDPSDKDSE--PFIETDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
P+ + DP + P + DP RY R LG G K Y D + EV +V
Sbjct: 17 PSAHVDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKV 74
Query: 59 KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY 118
++ P E++ +E+ + K+L N +++ H + D+D + + E+C +L E
Sbjct: 75 VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLEL 132
Query: 119 RKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K+ + V+ + + +Q ++G+ YLH + VIHRDL N+F+N + VKIGD
Sbjct: 133 HKRRKAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 186
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 74.7 bits (182), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 14/173 (8%)
Query: 10 SDKDSEPFIE-----TDP--TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRT 62
SD S P E DP RY R LG G K Y D + EV +V ++
Sbjct: 5 SDPKSAPLKEIPDVLVDPRTMKRYMR-GRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKS 62
Query: 63 FCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH 122
P E++ +E+ + K+L N +++ H + D+D + + E+C +L E K+
Sbjct: 63 MLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDD--FVYVVLEICRRRSLLELHKRR 120
Query: 123 RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ V+ + + +Q ++G+ YLH + VIHRDL N+F+N + VKIGD
Sbjct: 121 KAVTEPEARYFMRQTIQGVQYLHNNR--VIHRDLKLGNLFLNDDM-DVKIGDF 170
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 72.0 bits (175), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 49/152 (32%), Positives = 83/152 (54%), Gaps = 10/152 (6%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
R + +G G +VYRA +G+ VA +V++ D A + E+ LLK L + N
Sbjct: 35 RIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHPN 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNL----REYRKKHRHVSVKALKKWSKQILKGLNY 143
+I +Y ED N LN + E+ +G+L + ++K+ R + + + K+ Q+ L +
Sbjct: 94 VIK-YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+H+ V+HRD+ +NVF+ TG VK+GDL
Sbjct: 152 MHSRR--VMHRDIKPANVFITA-TGVVKLGDL 180
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 69.3 bits (168), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 76/145 (52%), Gaps = 7/145 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LLG G+ VYRA G+EVA + + M++R+ +EV++ L + +I+ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMY-KAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWSKQILKGLNYLHTHEPC 150
+ + ED N + + E+C +G + Y K + S + + QI+ G+ YLH+H
Sbjct: 77 YNYF--EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH--G 132
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL SN+ + N +KI D
Sbjct: 133 ILHRDLTLSNLLLTRNM-NIKIADF 156
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 67.0 bits (162), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 53/171 (30%), Positives = 86/171 (50%), Gaps = 14/171 (8%)
Query: 13 DSEPFIETDPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCD 65
+ +P E DPT R+ + LG G KV Y G +VA +K + +
Sbjct: 6 EKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGN 65
Query: 66 DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH- 124
I L E+ +L+ L ++NI+ + ++ N + I E SG+L+EY K+++
Sbjct: 66 H---IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK 122
Query: 125 VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++K K++ QI KG++YL + + +HRDL NV V QVKIGD
Sbjct: 123 INLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEH-QVKIGDF 170
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 66.6 bits (161), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 6 NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
NS S D +P I G Y R + +G G KV A G EVA +
Sbjct: 2 NSITSATDEQPHI-----GNY-RLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQL-- 53
Query: 66 DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
+P +++LF EVR++K L + NI+ L V E TL + E + G + +Y H +
Sbjct: 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRM 111
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K + +QI+ + Y H+ ++HRDL N+ ++G+ +KI D
Sbjct: 112 KEKEARAKFRQIVSAVQY--CHQKYIVHRDLKAENLLLDGDM-NIKIADF 158
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 65.9 bits (159), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 47/151 (31%), Positives = 79/151 (52%), Gaps = 15/151 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G VY+ ++ G+ VA +VKL + P+ R E+ L+K L ++NI+
Sbjct: 11 EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---EISLMKELKHENIVR 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKH------RHVSVKALKKWSKQILKGLNYL 144
L+ V E++ TL F +L++Y R + + +K + Q+L+GL +
Sbjct: 68 LYDVIHTENKLTLVF---EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF- 123
Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
HE ++HRDL N+ +N GQ+K+GD
Sbjct: 124 -CHENKILHRDLKPQNLLIN-KRGQLKLGDF 152
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 48 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 107 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 162
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 163 IHRDLKLGNLFLNEDL-EVKIGDF 185
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 28 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 87 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 142
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 143 IHRDLKLGNLFLNEDL-EVKIGDF 165
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 46 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 105 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 160
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 161 IHRDLKLGNLFLNEDL-EVKIGDF 183
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 24 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 83 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDF 161
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 24 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 83 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 139 IHRDLKLGNLFLNEDL-EVKIGDF 161
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 65.1 bits (157), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 76/144 (52%), Gaps = 6/144 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LG G K + D + EV ++ ++ P E++ E+ + ++LA+++++
Sbjct: 22 FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
H + ED + + + E+C +L E K+ + ++ + + +QI+ G YLH + V
Sbjct: 81 HGFF--EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR--V 136
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+F+N + +VKIGD
Sbjct: 137 IHRDLKLGNLFLNEDL-EVKIGDF 159
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 64.7 bits (156), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 46/145 (31%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G V++A ++E VA +V+L DD + E+ LLK L +KNI+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH V + + TL F E C + + + + + +K + Q+LKGL + H+
Sbjct: 66 LHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N N G++K+ D
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLADF 145
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 6 NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
NS S D +P I G Y R + +G G KV A G EVA +
Sbjct: 2 NSIASCADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-- 53
Query: 66 DPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV 125
+P +++LF EVR++K L + NI+ L V E TL I E + G + +Y H +
Sbjct: 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRM 111
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K + +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 112 KEKEARSKFRQIVSAVQY--CHQKRIVHRDLKAENLLLDADM-NIKIADF 158
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 62.8 bits (151), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 7/145 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G V++A ++E VA +V+L DD + E+ LLK L +KNI+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDD--DDEGVPSSALREICLLKELKHKNIVR 65
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH V + + TL F E C + + + + + +K + Q+LKGL + H+
Sbjct: 66 LHDVLHSDKKLTLVF--EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN-- 121
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N N G++K+ +
Sbjct: 122 VLHRDLKPQNLLINRN-GELKLANF 145
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 62.4 bits (150), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 33 LGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
LG G KV Y G +VA +K + + A +++ E+ +L+ L ++NI
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKK---EIEILRNLYHENI 73
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTH 147
+ + ++ N + I E SG+L+EY K+++ +++K K++ QI KG++YL +
Sbjct: 74 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 133
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +HRDL NV V QVKIGD
Sbjct: 134 Q--YVHRDLAARNVLVESEH-QVKIGDF 158
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 62.4 bits (150), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 39/101 (38%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LREY +KH+ + L +++
Sbjct: 64 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYT 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 124 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 14 SEPFIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDD 66
S F + DPT R+ ++ + LG G V Y G VA +++ T
Sbjct: 1 SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---- 56
Query: 67 PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-V 125
+ E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ +
Sbjct: 57 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 116
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 117 DHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 163
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 62.0 bits (149), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 15/170 (8%)
Query: 14 SEPFIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDD 66
S F + DPT R+ ++ + LG G V Y G VA +++ T
Sbjct: 3 SGAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---- 58
Query: 67 PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-V 125
+ E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ +
Sbjct: 59 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERI 118
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 119 DHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 165
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 62.0 bits (149), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 54/177 (30%), Positives = 80/177 (45%), Gaps = 17/177 (9%)
Query: 4 AVNSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVK 59
A+ S D+D F E R+ ++ + LG G V Y G VA +++
Sbjct: 25 AMGSAFEDRDPTQFEE-----RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQ 79
Query: 60 LRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYR 119
T + E+ +LK+L + NI+ V R L I E G+LR+Y
Sbjct: 80 HST----EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL 135
Query: 120 KKHRH-VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+KH+ + L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 136 QKHKERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 189
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 61.6 bits (148), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 17 FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
F + DPT R+ ++ + LG G V Y G VA +++ T
Sbjct: 3 FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 58
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVK 128
+ E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ +
Sbjct: 59 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 118
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 119 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 162
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 61.6 bits (148), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/167 (31%), Positives = 77/167 (46%), Gaps = 15/167 (8%)
Query: 17 FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
F + DPT R+ ++ + LG G V Y G VA +++ T
Sbjct: 5 FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 60
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVK 128
+ E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ +
Sbjct: 61 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI 120
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 121 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 164
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 20 TDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
+DPT R+ ++ + LG G V Y G VA +++ T +
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRD 57
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALK 131
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 60.8 bits (146), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 50/146 (34%), Positives = 67/146 (45%), Gaps = 9/146 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E++G G KVYRAF G EVA + D IE + E +L L + NII+
Sbjct: 13 EIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
L V E L + E G L R + L W+ QI +G+NYLH
Sbjct: 71 LRGVCLKEP--NLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 151 -VIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL SN+ + +V+ GDL
Sbjct: 128 PIIHRDLKSSNILI---LQKVENGDL 150
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 60.8 bits (146), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 51/164 (31%), Positives = 76/164 (46%), Gaps = 15/164 (9%)
Query: 20 TDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
+DPT R+ ++ + LG G V Y G VA +++ T +
Sbjct: 2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEHLRD 57
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALK 131
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 118 QYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 60.8 bits (146), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 59 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 118
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 119 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 156
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 60.5 bits (145), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 64 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 124 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 60.5 bits (145), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 13/163 (7%)
Query: 13 DSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
D +P I G Y R + +G G KV A G EVA + +P +++
Sbjct: 6 DEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL--NPTSLQK 57
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
LF EVR++K L + NI+ L V E TL I E + G + +Y H + K +
Sbjct: 58 LFREVRIMKILNHPNIVKLFEVI--ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 115
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 116 KFRQIVSAVQY--CHQKRIVHRDLKAENLLLDADM-NIKIADF 155
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 61 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 120
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 121 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 158
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 60 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 119
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 120 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 157
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 79 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 139 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 176
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 60.5 bits (145), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 38/101 (37%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 79 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 138
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 139 SQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 176
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 60.1 bits (144), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 79/155 (50%), Gaps = 12/155 (7%)
Query: 25 RYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
RY R +L G G +VY+A D VA +++L ++ + EV LLK L
Sbjct: 35 RYRRITKL-GEGTYGEVYKAIDTVTNETVAIKRIRLEH--EEEGVPGTAIREVSLLKELQ 91
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
++NII L V R L+ I E +L++Y K+ VS++ +K + Q++ G+N+
Sbjct: 92 HRNIIELKSVIHHNHR--LHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 145 HTHEPCVIHRDLNCSNVFVN----GNTGQVKIGDL 175
H+ C +HRDL N+ ++ T +KIGD
Sbjct: 149 HSRR-C-LHRDLKPQNLLLSVSDASETPVLKIGDF 181
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 59.3 bits (142), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
EPF + Y E LGSG V + ++ G+E A +K R + R
Sbjct: 3 EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
+ EV +L+ + + N+I+LH V+ E+R + I E+ + G L ++ + +S +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
+ KQIL G+NYLHT + + H DL N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
EPF + Y E LGSG V + ++ G+E A +K R + R
Sbjct: 3 EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
+ EV +L+ + + N+I+LH V+ E+R + I E+ + G L ++ + +S +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
+ KQIL G+NYLHT + + H DL N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
EPF + Y E LGSG V + ++ G+E A +K R + R
Sbjct: 3 EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
+ EV +L+ + + N+I+LH V+ E+R + I E+ + G L ++ + +S +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
+ KQIL G+NYLHT + + H DL N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI--ER 72
EPF + Y E LGSG V + ++ G+E A +K R + E
Sbjct: 3 EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
+ EV +L+ + + N+I+LH V+ E+R + I E+ + G L ++ + +S +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
+ KQIL G+NYLHT + + H DL N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 42/135 (31%), Positives = 70/135 (51%), Gaps = 6/135 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMI--ERLFSEVRLLKTLANKNI 88
E LGSG V + ++ G+E A +K R + E + EV +L+ + + NI
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH V+ E+R + I E+ + G L ++ + +S + + KQIL G+NYLHT +
Sbjct: 78 ITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 149 PCVIHRDLNCSNVFV 163
+ H DL N+ +
Sbjct: 136 --IAHFDLKPENIML 148
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 58.9 bits (141), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 15 EPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-- 72
EPF + Y E LGSG V + ++ G+E A +K R + R
Sbjct: 3 EPFKQQKVEDFYD-IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
+ EV +L+ + + N+I+LH V+ E+R + I E+ + G L ++ + +S +
Sbjct: 62 IEREVSILRQVLHHNVITLHDVY--ENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
+ KQIL G+NYLHT + + H DL N+ +
Sbjct: 120 FIKQILDGVNYLHTKK--IAHFDLKPENIML 148
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWS 134
E+ +LK+L + NI+ V R L I E G+LR+Y +KH+ + L +++
Sbjct: 62 EIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT 121
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI KG+ YL T IHR+L N+ V N +VKIGD
Sbjct: 122 SQICKGMEYLGTKR--YIHRNLATRNILVE-NENRVKIGDF 159
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 58.5 bits (140), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 51/167 (30%), Positives = 75/167 (44%), Gaps = 15/167 (8%)
Query: 17 FIETDPTG---RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
F + DPT R+ ++ + LG G V Y G VA +++ T
Sbjct: 2 FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST----EEH 57
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVK 128
+ E+ +LK+L + NI+ V R L I E G+LR+Y + H +
Sbjct: 58 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI 117
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +++ QI KG+ YL T IHRDL N+ V N +VKIGD
Sbjct: 118 KLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVE-NENRVKIGDF 161
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 58.2 bits (139), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR++K L + NI+ L V E TL + E + G + +Y H + K
Sbjct: 57 LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 57.8 bits (138), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR++K L + NI+ L V E TL + E + G + +Y H + K
Sbjct: 57 LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 57.8 bits (138), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR++K L + NI+ L V E TL + E + G + +Y H + K
Sbjct: 57 LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 57.8 bits (138), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR++K L + NI+ L V E TL + E + G + +Y H + K
Sbjct: 57 LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 57.8 bits (138), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 4/101 (3%)
Query: 75 SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
E+ +L+TL +++II D +L + E G+LR+Y +H + + L ++
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 140
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+QI +G+ YLH IHRDL NV ++ N VKIGD
Sbjct: 141 QQICEGMAYLHAQH--YIHRDLAARNVLLD-NDRLVKIGDF 178
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 57.8 bits (138), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR++K L + NI+ L V E TL + E + G + +Y H + K
Sbjct: 57 LQKLFREVRIMKVLNHPNIVKLFEVI--ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADM-NIKIADF 157
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 57.0 bits (136), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 56/101 (55%), Gaps = 4/101 (3%)
Query: 75 SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
E+ +L+TL +++II D+ +L + E G+LR+Y +H + + L ++
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+QI +G+ YLH+ IHR+L NV ++ N VKIGD
Sbjct: 124 QQICEGMAYLHSQH--YIHRNLAARNVLLD-NDRLVKIGDF 161
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 57.0 bits (136), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21 DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
DPT R+ +Y LG G V Y G VA Q++ P
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 71
Query: 74 FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
E+++LK L + I+ V R +L + E SG LR++ ++HR + L
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+S QI KG+ YL + +HRDL N+ V + VKI D
Sbjct: 132 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 171
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 57.0 bits (136), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21 DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
DPT R+ +Y LG G V Y G VA Q++ P
Sbjct: 4 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 59
Query: 74 FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
E+++LK L + I+ V R +L + E SG LR++ ++HR + L
Sbjct: 60 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 119
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+S QI KG+ YL + +HRDL N+ V + VKI D
Sbjct: 120 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 159
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 57.0 bits (136), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 32/106 (30%), Positives = 58/106 (54%), Gaps = 4/106 (3%)
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
IE+++ E+ +LK L + N++ L V D + + L + E+ G + E + +S
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV-PTLKPLSEDQ 138
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + + ++KG+ YLH + +IHRD+ SN+ V G G +KI D
Sbjct: 139 ARFYFQDLIKGIEYLHYQK--IIHRDIKPSNLLV-GEDGHIKIADF 181
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 57.0 bits (136), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 70/163 (42%), Gaps = 15/163 (9%)
Query: 21 DPT---GRYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
DPT R+ +Y LG G V Y G VA Q++ P
Sbjct: 3 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDF 58
Query: 74 FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKK 132
E+++LK L + I+ V R +L + E SG LR++ ++HR + L
Sbjct: 59 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 118
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+S QI KG+ YL + +HRDL N+ V + VKI D
Sbjct: 119 YSSQICKGMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 158
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 56.6 bits (135), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 4/101 (3%)
Query: 75 SEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
E+ +L+TL +++II D+ +L + E G+LR+Y +H + + L ++
Sbjct: 65 QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFA 123
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+QI +G+ YLH IHR+L NV ++ N VKIGD
Sbjct: 124 QQICEGMAYLHAQH--YIHRNLAARNVLLD-NDRLVKIGDF 161
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 56.6 bits (135), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
+G GA KV++A D + G VA +V+++T + P R + +R L+T + N++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91 LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
L V R + L + E +L Y K V + +K Q+L+GL++LH
Sbjct: 79 LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+H V+HRDL N+ V ++GQ+K+ D
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKSQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN ++ ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 169
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
+G GA KV++A D + G VA +V+++T + P R + +R L+T + N++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91 LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
L V R + L + E +L Y K V + +K Q+L+GL++LH
Sbjct: 79 LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+H V+HRDL N+ V ++GQ+K+ D
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 56.6 bits (135), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 11/150 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIE-VAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNIIS 90
+G GA KV++A D + G VA +V+++T + P R + +R L+T + N++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 91 LH---YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLH 145
L V R + L + E +L Y K V + +K Q+L+GL++LH
Sbjct: 79 LFDVCTVSRTDRETKLTLVFE-HVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+H V+HRDL N+ V ++GQ+K+ D
Sbjct: 138 SHR--VVHRDLKPQNILVT-SSGQIKLADF 164
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 56.2 bits (134), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 38/135 (28%), Positives = 68/135 (50%), Gaps = 6/135 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V++ +++ G VA K DDP + + E+R+LK L + N+++L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIK--KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
V+R + R L+ + E C L E + R V +K + Q L+ +N+ H H I
Sbjct: 69 EVFRRKRR--LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN--CI 124
Query: 153 HRDLNCSNVFVNGNT 167
HRD+ N+ + ++
Sbjct: 125 HRDVKPENILITKHS 139
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 55.8 bits (133), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G KV A G EVA + + + +++LF EVR++K L + NI+ L
Sbjct: 15 IGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
V E TL + E + G + +Y H + K + +QI+ + Y H+ ++
Sbjct: 73 EVI--ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQY--CHQKFIV 128
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRDL N+ ++ + +KI D
Sbjct: 129 HRDLKAENLLLDADM-NIKIADF 150
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
T RY E+ G GA VY+A D G VA V++ + P R + +R L+
Sbjct: 3 TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82 TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
+ N++ L V DR + +LR Y K + A +K +Q
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L+GL++LH + C++HRDL N+ V G VK+ D
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 169
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
T RY E+ G GA VY+A D G VA V++ + P R + +R L+
Sbjct: 3 TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82 TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
+ N++ L V DR + +LR Y K + A +K +Q
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L+GL++LH + C++HRDL N+ V G VK+ D
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 55.5 bits (132), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/158 (29%), Positives = 71/158 (44%), Gaps = 9/158 (5%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLK 81
T RY E+ G GA VY+A D G VA V++ + P R + +R L+
Sbjct: 3 TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 82 TLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQI 137
+ N++ L V DR + +LR Y K + A +K +Q
Sbjct: 62 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L+GL++LH + C++HRDL N+ V G VK+ D
Sbjct: 122 LRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 156
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 55.5 bits (132), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G VY D + +A ++ R D + L E+ L K L +KNI+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIV-- 82
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
Y+ + + E G+L R K + + + + ++KQIL+GL YLH ++
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRD+ NV +N +G +KI D
Sbjct: 143 --IVHRDIKGDNVLINTYSGVLKISDF 167
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 87 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN ++ ++KI D
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 175
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 11/147 (7%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G VY D + +A ++ R D + L E+ L K L +KNI+
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPER----DSRYSQPLHEEIALHKHLKHKNIV-- 68
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
Y+ + + E G+L R K + + + + ++KQIL+GL YLH ++
Sbjct: 69 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRD+ NV +N +G +KI D
Sbjct: 129 --IVHRDIKGDNVLINTYSGVLKISDF 153
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 83 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN ++ ++KI D
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDS-ELKILDF 171
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKXQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 13/166 (7%)
Query: 10 SDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM 69
+ D +P I G Y R + +G G KV A G EVA + + +
Sbjct: 5 TSADEQPHI-----GNY-RLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQL--NSSS 56
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+++LF EVR+ K L + NI+ L V E TL + E + G + +Y H K
Sbjct: 57 LQKLFREVRIXKVLNHPNIVKLFEVI--ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKE 114
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +QI+ + Y H+ ++HRDL N+ ++ + +KI D
Sbjct: 115 ARAKFRQIVSAVQY--CHQKFIVHRDLKAENLLLDADX-NIKIADF 157
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E S +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 KLLDVIHTE--NKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 55.1 bits (131), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 66/156 (42%), Gaps = 12/156 (7%)
Query: 25 RYGRYNELLGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
R+ +Y LG G V Y G VA Q++ P E+++L
Sbjct: 7 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH----SGPDQQRDFQREIQIL 62
Query: 81 KTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILK 139
K L + I+ V R L + E SG LR++ ++HR + L +S QI K
Sbjct: 63 KALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
G+ YL + +HRDL N+ V + VKI D
Sbjct: 123 GMEYLGSRR--CVHRDLAARNILVE-SEAHVKIADF 155
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 28 RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 86 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 174
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 54.7 bits (130), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/161 (29%), Positives = 70/161 (43%), Gaps = 12/161 (7%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVR 78
T RY E+ G GA VY+A D G VA V++ P R + +R
Sbjct: 8 TSRYEPVAEI-GVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 79 LLKTLANKNIISLHYVWRDE--DRNTLNFITEVCTSGNLREYRKKHRHVSVKA--LKKWS 134
L+ + N++ L V DR + +LR Y K + A +K
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+Q L+GL++LH + C++HRDL N+ V G VK+ D
Sbjct: 127 RQFLRGLDFLHAN--CIVHRDLKPENILVTSG-GTVKLADF 164
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 11 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 67
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E S +L+++ + + +K + Q+L+GL + H+H
Sbjct: 68 KLLDVIHTE--NKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 125 R--VLHRDLKPQNLLIN-TEGAIKLADF 149
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 54.7 bits (130), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 5/134 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G + VY A D I+VA + + + ++R EV L+++NI+S+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPP-REKEETLKRFEREVHNSSQLSHQNIVSM- 76
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ DE+ + + E L EY + H +SV ++ QIL G+ H H+ ++
Sbjct: 77 -IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK--HAHDMRIV 133
Query: 153 HRDLNCSNVFVNGN 166
HRD+ N+ ++ N
Sbjct: 134 HRDIKPQNILIDSN 147
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 54.3 bits (129), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 34 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 91
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 92 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 180
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 81 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 86 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDX-ELKILDF 174
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 45/148 (30%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E S +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 KLLDVIHTE--NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 R--VLHRDLKPENLLIN-TEGAIKLADF 150
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 81 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 14/163 (8%)
Query: 20 TDPTGRYGRYNEL---LGSGAVKKV----YRAFDQEEGIEVAWNQVKLRTFCDDPAMIER 72
+DPT + RY + LG G KV Y + G VA L+ C P +
Sbjct: 1 SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK--ALKEGCG-PQLRSG 57
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK 132
E+ +L+TL +++I+ D+ ++ + E G+LR+Y +H V + L
Sbjct: 58 WQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLL 116
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++QI +G+ YLH IHR L NV ++ N VKIGD
Sbjct: 117 FAQQICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDF 156
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 85 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 85 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 42 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 99
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 188
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 46 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 102
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 103 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 159
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 160 DRR--LVHRDLAARNVLVK-TPQHVKITDF 186
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 80 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 80 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 43/147 (29%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 10 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E S +L+++ + + +K + Q+L+GL + H+H
Sbjct: 68 LLDVIHTE--NKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 125 --VLHRDLKPENLLIN-TEGAIKLADF 148
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 21 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 78
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 79 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 136
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 137 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 167
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 81 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 87 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 27 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 83
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 84 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 140
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 141 DRR--LVHRDLAARNVLVK-TPQHVKITDF 167
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 80/154 (51%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA KL +R + E+RLLK + +
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSKPFQSIIHAKRTYRELRLLKHMKH 92
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 93 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 46 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 103
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 192
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 92
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 93 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 54.3 bits (129), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 35 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 92
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 93 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 150
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 151 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 181
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 86 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 174
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 71
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 72 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 129 DRR--LVHRDLAARNVLVK-TPQHVKITDF 155
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 34 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 91
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 92 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 149
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 150 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 180
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 20 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 77
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 78 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 166
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 54.3 bits (129), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 32/100 (32%), Positives = 54/100 (54%), Gaps = 4/100 (4%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSK 135
E+ +L+TL +++I+ D+ ++ + E G+LR+Y +H V + L +++
Sbjct: 60 EIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC-VGLAQLLLFAQ 118
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI +G+ YLH IHR L NV ++ N VKIGD
Sbjct: 119 QICEGMAYLHAQH--YIHRALAARNVLLD-NDRLVKIGDF 155
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 20 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 77
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 78 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 135
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 136 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 166
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 87 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 46 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 103
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 104 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 161
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 162 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 192
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 83 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 31 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 87
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 88 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 144
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 145 DRR--LVHRDLAARNVLVK-TPQHVKITDF 171
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 83 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 25 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 83 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 141 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 171
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 87
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 145
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 146 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 176
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 53.9 bits (128), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 28 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 85
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 86 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 143
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 144 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 174
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 22 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 79
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 80 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 137
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 138 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 168
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 53.9 bits (128), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 50/153 (32%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILD 168
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 53.5 bits (127), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEG--IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
++LGSGA VY+ EG +++ ++LR P + + E ++ ++ N ++
Sbjct: 55 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELRE-ATSPKANKEILDEAYVMASVDNPHV 113
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTH 147
L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 114 CRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 170
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 171 R--LVHRDLAARNVLVK-TPQHVKITDF 195
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 53.5 bits (127), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/143 (32%), Positives = 76/143 (53%), Gaps = 12/143 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G+ VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVN 164
Y+H+ + +IHRDL SN+ VN
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVN 159
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 53.5 bits (127), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL++ H+H
Sbjct: 66 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 71 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 129 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 161
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 10/149 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G+GA V A + G +VA K+ D +R E+++LK + NII+
Sbjct: 61 ETIGNGAYGVVSSARRRLTGQQVAIK--KIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 118
Query: 91 LHYVWRDE----DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
+ + R + ++ + ++ S +L + + ++++ ++ + Q+L+GL Y+H+
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 177
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ VIHRDL SN+ VN N ++KIGD
Sbjct: 178 AQ--VIHRDLKPSNLLVNENC-ELKIGDF 203
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 71 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 129 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 161
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 16 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 73 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADF 154
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 16 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 72
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 73 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 130 R--VLHRDLKPQNLLIN-TEGAIKLADF 154
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 53.1 bits (126), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 37/135 (27%), Positives = 69/135 (51%), Gaps = 6/135 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
E LGSG V + ++ G++ A +K R + R + EV +LK + + N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ YLH+ +
Sbjct: 77 ITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PCVIHRDLNCSNVFV 163
+ H DL N+ +
Sbjct: 135 --IAHFDLKPENIML 147
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 9/150 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
E LGSG V + ++ G++ A +K R + R + EV +LK + + N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ YLH+ +
Sbjct: 77 ITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ 134
Query: 149 PCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
+ H DL N+ + N ++KI D
Sbjct: 135 --IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 69
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 70 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 127 --VLHRDLKPQNLLIN-TEGAIKLADF 150
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPENLLIN-TEGAIKLADF 147
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 11 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 --VLHRDLKPQNLLIN-TEGAIKLADF 149
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 9/155 (5%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTL 83
Y E LGSG V + ++ G++ A +K R + R + EV +LK +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ N+I+LH V+ E++ + I E+ G L ++ + ++ + ++ KQIL G+ Y
Sbjct: 72 QHPNVITLHEVY--ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 129
Query: 144 LHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
LH+ + + H DL N+ + N ++KI D
Sbjct: 130 LHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDF 162
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 78
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 79 HVCRLLGICLT---STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 136 DRR--LVHRDLAARNVLVK-TPQHVKITDF 162
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 11 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 --VLHRDLKPQNLLIN-TEGAIKLADF 149
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 15/150 (10%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-----CDDPAMIER----LFSEVRLLKTL 83
LGSGA +V ++ E A +K F DD IE+ +++E+ LLK+L
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLN 142
+ NII L V+ ED+ +TE G L E +H+ A KQIL G+
Sbjct: 104 DHPNIIKLFDVF--EDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-ANIMKQILSGIC 160
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKI 172
YLH H ++HRD+ N+ + + I
Sbjct: 161 YLHKHN--IVHRDIKPENILLENKNSLLNI 188
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP +Y R+ E +G GA VY A D G EVA Q+ L+ P E + +E+ ++
Sbjct: 18 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 72
Query: 81 KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
+ N NI++ Y+ DE L + E G+L + + + + ++ L
Sbjct: 73 RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 127
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L +LH+++ VIHRD+ N+ + G G VK+ D
Sbjct: 128 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 161
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 10 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 68 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 125 --VLHRDLKPQNLLIN-TEGAIKLADF 148
>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From
Toxoplasma Gondii, 541.m00134, Kinase Domain
Length = 287
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
+ RY R +L GSGA +V D+ G E A +K ++ + L EV +LK
Sbjct: 20 SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIK-KSSVTTTSNSGALLDEVAVLKQ 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKWSKQILK 139
L + NI+ L+ + ED+ + EV G L + R+K V + KQ+L
Sbjct: 78 LDHPNIMKLYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 132
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
G YLH H ++HRDL N+ + + +KI D
Sbjct: 133 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDF 168
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 13 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 70 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADF 151
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 13 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 69
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 70 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 127 R--VLHRDLKPQNLLIN-TEGAIKLADF 151
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 18 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 74
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI +G+NYL
Sbjct: 75 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE 131
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 132 DRR--LVHRDLAARNVLVK-TPQHVKITDF 158
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 11 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 68
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 69 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 --VLHRDLKPENLLIN-TEGAIKLADF 149
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 52.8 bits (125), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 10 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 68 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 125 --VLHRDLKPENLLIN-TEGAIKLADF 148
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP +Y R+ E +G GA VY A D G EVA Q+ L+ P E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81 KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
+ N NI++ Y+ DE L + E G+L + + + + ++ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L +LH+++ VIHRD+ N+ + G G VK+ D
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 65 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 10 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 66
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 R--VLHRDLKPQNLLIN-TEGAIKLADF 148
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP +Y R+ E +G GA VY A D G EVA Q+ L+ P E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81 KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
+ N NI++ Y+ DE L + E G+L + + + + ++ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L +LH+++ VIHRD+ N+ + G G VK+ D
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/149 (28%), Positives = 79/149 (53%), Gaps = 10/149 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G+GA V A + G +VA K+ D +R E+++LK + NII+
Sbjct: 60 ETIGNGAYGVVSSARRRLTGQQVAIK--KIPNAFDVVTNAKRTLRELKILKHFKHDNIIA 117
Query: 91 LHYVWRDE----DRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
+ + R + ++ + ++ S +L + + ++++ ++ + Q+L+GL Y+H+
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS 176
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ VIHRDL SN+ VN N ++KIGD
Sbjct: 177 AQ--VIHRDLKPSNLLVNENC-ELKIGDF 202
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 69
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E++ L F +L+++ + + +K + Q+L+GL + H+H
Sbjct: 70 LLDVIHTENKLYLVF---EHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 126
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 127 --VLHRDLKPQNLLIN-TEGAIKLADF 150
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 10 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 68 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 124
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 125 --VLHRDLKPQNLLIN-TEGAIKLADF 148
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 436
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 437 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 491
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 492 HRDLAARNVLL 502
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP +Y R+ E +G GA VY A D G EVA Q+ L+ P E + +E+ ++
Sbjct: 17 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 71
Query: 81 KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
+ N NI++ Y+ DE L + E G+L + + + + ++ L
Sbjct: 72 RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L +LH+++ VIHRD+ N+ + G G VK+ D
Sbjct: 127 QALEFLHSNQ--VIHRDIKSDNILL-GMDGSVKLTDF 160
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 65 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 437
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 438 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 492
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 493 HRDLAARNVLL 503
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 66 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 66 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 52.8 bits (125), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 66 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 81
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 82 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 139 DRR--LVHRDLAARNVLVK-TPQHVKITDF 165
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 66
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 67 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 123
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 124 --VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 66 LLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLA 79
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 80 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTSDLKICDF 170
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 80
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 81 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 137
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 138 DRR--LVHRDLAARNVLVK-TPQHVKITDF 164
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 9 EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 65
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 66 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 R--VLHRDLKPQNLLIN-TEGAIKLADF 147
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 64
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+++ + + +K + Q+L+GL + H+H
Sbjct: 65 KLLDVIHTE--NKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 122 R--VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 73/148 (49%), Gaps = 12/148 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD-PAMIERLFSEVRLLKTLANKNII 89
E +G G VY+A ++ G VA +++L T + P+ R E+ LLK L + NI+
Sbjct: 12 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR---EISLLKELNHPNIV 68
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTH 147
L V E N L + E +L+ + + + +K + Q+L+GL + H+H
Sbjct: 69 KLLDVIHTE--NKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 126 R--VLHRDLKPQNLLIN-TEGAIKLADF 150
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 80 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 81
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 82 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 138
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 139 DRR--LVHRDLAARNVLVK-TPQHVKITDF 165
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA KVY+A ++E + A + ++ +E E+ +L + + NI+ L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ E N L + E C G + + R ++ ++ KQ L LNYLH ++ +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+ + G +K+ D
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 80 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 49/163 (30%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 21 DPTGRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER-LFSEV 77
D R RY +L LG G VY+A D+ VA ++KL + I R E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 78 RLLKTLANKNIISLHYVWRDEDRNTLNF-----ITEVCTSGNLREYRKKHRHVSVKALKK 132
+LL+ L++ NII L + + +L F EV N H +K
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH-------IKA 116
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L+GL YLH H ++HRDL +N+ ++ N G +K+ D
Sbjct: 117 YMLMTLQGLEYLHQH--WILHRDLKPNNLLLDEN-GVLKLADF 156
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 78
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 79 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 135
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 136 DRR--LVHRDLAARNVLVK-TPQHVKITDF 162
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 79
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 80 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 136
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 137 DRR--LVHRDLAARNVLVK-TPQHVKITDF 163
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA KVY+A ++E + A + ++ +E E+ +L + + NI+ L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ E N L + E C G + + R ++ ++ KQ L LNYLH ++ +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+ + G +K+ D
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 52.4 bits (124), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA KVY+A ++E + A + ++ +E E+ +L + + NI+ L
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIVKLL 100
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ E N L + E C G + + R ++ ++ KQ L LNYLH ++ +
Sbjct: 101 DAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK--I 156
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+ + G +K+ D
Sbjct: 157 IHRDLKAGNILFTLD-GDIKLADF 179
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/158 (30%), Positives = 73/158 (46%), Gaps = 14/158 (8%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKT 82
+ RY R +L GSGA +V D+ G E A +K ++ + L EV +LK
Sbjct: 3 SDRYQRVKKL-GSGAYGEVLLCKDKLTGAERAIKIIK-KSSVTTTSNSGALLDEVAVLKQ 60
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKWSKQILK 139
L + NI+ L+ + ED+ + EV G L + R+K V + KQ+L
Sbjct: 61 LDHPNIMKLYEFF--EDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVI---MKQVLS 115
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
G YLH H ++HRDL N+ + + +KI D
Sbjct: 116 GTTYLHKHN--IVHRDLKPENLLLESKSRDALIKIVDF 151
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 52.0 bits (123), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 43 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 100
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 101 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 158
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 159 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 189
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 95 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 150 HRDLAARNVLL 160
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 35 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 94
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 95 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 149
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 150 HRDLAARNVLL 160
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 33 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 92
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 93 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 147
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 148 HRDLAARNVLL 158
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 29 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 86
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 87 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 145 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 175
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 42 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 99
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 100 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 158 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 188
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++L SGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 85 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 79 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 134 HRDLAARNVLL 144
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 19 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 78
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 79 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 133
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 134 HRDLAARNVLL 144
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 85 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 139
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 140 HRDLAARNVLL 150
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 33 RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 90
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 91 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 148
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 149 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 179
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G+ +V D+ G E A + R E L EV+LLK L + NI+ L
Sbjct: 57 VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 115
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + ED+ + EV T G L + + S + +Q+L G+ Y+H ++ +
Sbjct: 116 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 171
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
+HRDL N+ + + I
Sbjct: 172 VHRDLKPENLLLESKSKDANI 192
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 51/162 (31%), Positives = 79/162 (48%), Gaps = 29/162 (17%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
EL+GSG +V++A + +G +VK E+ EV+ L L + NI+
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--------EKAEREVKALAKLDHVNIVH 68
Query: 91 LHYVWR--DEDRNT------------LNFITEVCTSGNLREYRKKHRHVS---VKALKKW 133
+ W D D T L E C G L ++ +K R V AL+ +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+QI KG++Y+H+ + +I+RDL SN+F+ +T QVKIGD
Sbjct: 129 -EQITKGVDYIHSKK--LINRDLKPSNIFLV-DTKQVKIGDF 166
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 23 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 80
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 81 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 139 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 169
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 52.0 bits (123), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G+ +V D+ G E A + R E L EV+LLK L + NI+ L
Sbjct: 56 VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 114
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + ED+ + EV T G L + + S + +Q+L G+ Y+H ++ +
Sbjct: 115 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 170
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
+HRDL N+ + + I
Sbjct: 171 VHRDLKPENLLLESKSKDANI 191
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 13 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 72
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 73 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 127
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 128 HRDLAARNVLL 138
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G+ +V D+ G E A + R E L EV+LLK L + NI+ L
Sbjct: 39 VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 97
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + ED+ + EV T G L + + S + +Q+L G+ Y+H ++ +
Sbjct: 98 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 153
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
+HRDL N+ + + I
Sbjct: 154 VHRDLKPENLLLESKSKDANI 174
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 65/141 (46%), Gaps = 5/141 (3%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G+ +V D+ G E A + R E L EV+LLK L + NI+ L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + ED+ + EV T G L + + S + +Q+L G+ Y+H ++ +
Sbjct: 92 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK--I 147
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
+HRDL N+ + + I
Sbjct: 148 VHRDLKPENLLLESKSKDANI 168
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 47/154 (30%), Positives = 83/154 (53%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V ++D + G+++A ++ R F +R + E+RLLK + +
Sbjct: 52 RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 109
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 110 ENVIGLLDVFTPATSLEEFNDVYLVTHLM-GADLNNIVKCQK-LTDDHVQFLIYQILRGL 167
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 168 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 198
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 35/131 (26%), Positives = 63/131 (48%), Gaps = 5/131 (3%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LGSG V + + Q + + L+ +DPA+ + L +E +++ L N I+ +
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ E + + E+ G L +Y +++RHV K + + Q+ G+ YL E +
Sbjct: 75 GICEAE---SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL--EESNFV 129
Query: 153 HRDLNCSNVFV 163
HRDL NV +
Sbjct: 130 HRDLAARNVLL 140
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 72/150 (48%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++L SGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 21 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ IT++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 78 HVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 134
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 135 DRR--LVHRDLAARNVLVK-TPQHVKITDF 161
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 41/147 (27%), Positives = 71/147 (48%), Gaps = 10/147 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A ++ G VA +++L T + + E+ LLK L + NI+
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDT--ETEGVPSTAIREISLLKELNHPNIVK 65
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHE 148
L V E++ L F +L+ + + + +K + Q+L+GL + H+H
Sbjct: 66 LLDVIHTENKLYLVF---EHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ +N G +K+ D
Sbjct: 123 --VLHRDLKPQNLLIN-TEGAIKLADF 146
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
E LGSG V + + G E A +K R + R + EV +L+ + + NI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH ++ E++ + I E+ + G L ++ + ++ ++ KQIL G++YLH+
Sbjct: 71 ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 128
Query: 149 PCVIHRDLNCSNVFV 163
+ H DL N+ +
Sbjct: 129 --IAHFDLKPENIML 141
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 51.6 bits (122), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +K+ P E ++ ++ +
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 100
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
+++ L V T+ +T++ G L EY +H+ ++ + L W QI KG+ YL
Sbjct: 101 HLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V + VKI D
Sbjct: 158 ERR--LVHRDLAARNVLVK-SPNHVKITDF 184
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLA 79
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 80 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 170
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 50/154 (32%), Positives = 81/154 (52%), Gaps = 13/154 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V AFD + G VA ++ R F +R + E+RLLK + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS-RPF-QSIIHAKRTYRELRLLKHMKH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+N+I L V+ E+ N + +T + +L K + ++ ++ QIL+GL
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCAK-LTDDHVQFLIYQILRGL 134
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ + +IHRDL SN+ VN + ++KI D
Sbjct: 135 KYIHSAD--IIHRDLKPSNLAVNEDC-ELKILDF 165
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 78 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKIXDF 168
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
E LGSG V + + G E A +K R + R + EV +L+ + + NI
Sbjct: 18 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH ++ E++ + I E+ + G L ++ + ++ ++ KQIL G++YLH+
Sbjct: 78 ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 135
Query: 149 PCVIHRDLNCSNVFV 163
+ H DL N+ +
Sbjct: 136 --IAHFDLKPENIML 148
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 78 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 168
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 51.2 bits (121), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 7/145 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A D G +VA ++ R F + +R + E+RLLK + ++N+I L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSE-LFAKRAYRELRLLKHMRHENVIGLL 90
Query: 93 YVWRDEDR--NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V+ ++ + +F + G KH + ++ Q+LKGL Y+H
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA--G 148
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ VN + ++KI D
Sbjct: 149 IIHRDLKPGNLAVNEDC-ELKILDF 172
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 37/135 (27%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--LFSEVRLLKTLANKNI 88
E LGSG V + + G E A +K R + R + EV +L+ + + NI
Sbjct: 32 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
I+LH ++ E++ + I E+ + G L ++ + ++ ++ KQIL G++YLH+
Sbjct: 92 ITLHDIF--ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR 149
Query: 149 PCVIHRDLNCSNVFV 163
+ H DL N+ +
Sbjct: 150 --IAHFDLKPENIML 162
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 16/180 (8%)
Query: 2 MPAVNSDPSDKD---SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQV 58
MPA S KD +E F + DP + E+ G G+ VY A D VA ++
Sbjct: 29 MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKM 87
Query: 59 KLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNL 115
+ + + EVR L+ L + N I + E +T + E C S L
Sbjct: 88 SYSGKQSNEKW-QDIIKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLL 144
Query: 116 REYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++K + V + A+ + L+GL YLH+H +IHRD+ N+ ++ G VK+GD
Sbjct: 145 EVHKKPLQEVEIAAV---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 198
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 51.2 bits (121), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++LGSGA VY+ EG I VA +K+ P E ++ ++ +
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVA---IKILNETTGPKANVEFMDEALIMASMDHP 77
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
+++ L V T+ +T++ G L EY +H+ ++ + L W QI KG+ YL
Sbjct: 78 HLVRLLGVCLSP---TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYL- 133
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
E ++HRDL NV V + VKI D
Sbjct: 134 -EERRLVHRDLAARNVLVK-SPNHVKITDF 161
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28 RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
RYN +LG G+ +V + D+ E A + K D + I R EV LLK L
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
+ NI+ L + ED ++ + E+ T G L + K + S + KQ+ G+ Y+
Sbjct: 80 HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
H H ++HRDL N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 78 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 168
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 50.8 bits (120), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 82 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 172
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR-LLKTLA 84
Y +ELLG GA KV A + G E A ++ + R+F EV L +
Sbjct: 14 YKLTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQA----GHSRSRVFREVETLYQCQG 69
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
NKNI+ L + D+ R L F E G++ + +K +H + + + + + L++L
Sbjct: 70 NKNILELIEFFEDDTRFYLVF--EKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFL 127
Query: 145 HTHEPCVIHRDLNCSNVFVNG--NTGQVKIGDL 175
HT + HRDL N+ VKI D
Sbjct: 128 HTKG--IAHRDLKPENILCESPEKVSPVKICDF 158
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP +Y R+ E +G GA VY A D G EVA Q+ L+ P E + +E+ ++
Sbjct: 18 DPKKKYTRF-EKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKK-ELIINEILVM 72
Query: 81 KTLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
+ N NI++ Y+ DE L + E G+L + + + + ++ L
Sbjct: 73 RENKNPNIVNYLDSYLVGDE----LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECL 127
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L +LH+++ VIHR++ N+ + G G VK+ D
Sbjct: 128 QALEFLHSNQ--VIHRNIKSDNILL-GMDGSVKLTDF 161
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 50.8 bits (120), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 79/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY +L +G GA V A+D VA ++ + +T+C +R E+++L
Sbjct: 44 RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYC------QRTLREIQILLR 97
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++N+I + + R +TL + +V +L E Y+ K + +S + + QIL
Sbjct: 98 FRHENVIGIRDILR---ASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQIL 154
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLIN-TTCDLKICDF 188
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 78 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 168
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 32 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 85
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 86 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 142
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 143 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 176
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 50.4 bits (119), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 24 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 77
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 78 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 134
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 135 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 168
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 26 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 79
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 80 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 136
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 137 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 170
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 44 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 97
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 98 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 154
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 155 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 188
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28 RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
RYN +LG G+ +V + D+ E A + K D + I R EV LLK L
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
+ NI+ L + ED ++ + E+ T G L + K + S + KQ+ G+ Y+
Sbjct: 80 HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
H H ++HRDL N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 42/139 (30%), Positives = 66/139 (47%), Gaps = 10/139 (7%)
Query: 28 RYNE--LLGSGAVKKVYRAFDQEEGIEVAWNQV-KLRTFCDDPAMIERLFSEVRLLKTLA 84
RYN +LG G+ +V + D+ E A + K D + I R EV LLK L
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR---EVELLKKLD 79
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL 144
+ NI+ L + ED ++ + E+ T G L + K + S + KQ+ G+ Y+
Sbjct: 80 HPNIMKLFEIL--EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 145 HTHEPCVIHRDLNCSNVFV 163
H H ++HRDL N+ +
Sbjct: 138 HKHN--IVHRDLKPENILL 154
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 22 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 75
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 76 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 166
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 82 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 29 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 82
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 83 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 173
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY+ + VA +++L P R EV LLK L + NI++LH
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---EVSLLKDLKHANIVTLH 66
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYLHTHEPCV 151
+ E TL F +L++Y + +++ +K + Q+L+GL Y H + V
Sbjct: 67 DIIHTEKSLTLVF---EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK--V 121
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
+HRDL N+ +N G++K+ D
Sbjct: 122 LHRDLKPQNLLIN-ERGELKLADF 144
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 50.4 bits (119), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 81/175 (46%), Gaps = 42/175 (24%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
EL+GSG +V++A + +G +VK E+ EV+ L L + NI+
Sbjct: 18 ELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN--------EKAEREVKALAKLDHVNIVH 69
Query: 91 LHYVWRDED-----------------RNTLN---------FIT-EVCTSGNLREYRKKHR 123
+ W D N+ N FI E C G L ++ +K R
Sbjct: 70 YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 124 HVS---VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V AL+ + +QI KG++Y+H+ + +IHRDL SN+F+ +T QVKIGD
Sbjct: 130 GEKLDKVLALELF-EQITKGVDYIHSKK--LIHRDLKPSNIFLV-DTKQVKIGDF 180
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 22 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 75
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 76 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 133 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 166
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 29 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 82
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 83 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 139
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 140 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 173
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 38/139 (27%), Positives = 69/139 (49%), Gaps = 13/139 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G+G+ V+RA + G +VA + + F + + EV ++K L + NI+
Sbjct: 43 EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVL 98
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-----WSKQILKGLNYLH 145
++ L+ +TE + G+L YR H+ + + L + + + KG+NYLH
Sbjct: 99 --FMGAVTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 146 THEPCVIHRDLNCSNVFVN 164
P ++HRDL N+ V+
Sbjct: 155 NRNPPIVHRDLKSPNLLVD 173
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 30 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 83
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 84 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 140
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 141 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 174
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 21 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 74
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 75 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 131
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 132 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 165
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 82 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 50.4 bits (119), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYC------QRTLREIKILLR 81
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 82 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 50.1 bits (118), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 15/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 44 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 97
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQILKGL 141
++NII ++ + R + + V Y+ K +H+S + + QIL+GL
Sbjct: 98 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGL 157
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 158 KYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 188
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 8/153 (5%)
Query: 27 GRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
G+Y +LLG G+ KV D E A +K + P + E++LL+ L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR 64
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRK--KHRHVSVKALKKWSKQILKGLN 142
+KN+I L V +E++ + + E C G ++E + V + Q++ GL
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLE 123
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
YLH+ ++H+D+ N+ + G +KI L
Sbjct: 124 YLHSQG--IVHKDIKPGNLLLT-TGGTLKISAL 153
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/157 (29%), Positives = 80/157 (50%), Gaps = 21/157 (13%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQV---KLRTFCDDPAMIERLFSEVRLLKT 82
RY L +G GA V A+D + VA ++ + +T+C +R E+++L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC------QRTLREIKILLR 81
Query: 83 LANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQIL 138
++NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL
Sbjct: 82 FRHENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQIL 138
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+GL Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 139 RGLKYIHSAN--VLHRDLKPSNLLLN-TTCDLKICDF 172
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 50.1 bits (118), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 14/150 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
++L SGA VY+ EG I VA +++ T P + + E ++ ++ N
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNP 84
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLH 145
++ L + +T+ I ++ G L +Y ++H+ ++ + L W QI KG+NYL
Sbjct: 85 HVCRLLGICLT---STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 141
Query: 146 THEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL NV V VKI D
Sbjct: 142 DRR--LVHRDLAARNVLVK-TPQHVKITDF 168
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A +K + L +E R+L+ + +
Sbjct: 14 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 72
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R S + + +I+ L+YLH+ E
Sbjct: 73 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 129
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL N+ ++ + G +KI D
Sbjct: 130 KNVVYRDLKLENLMLDKD-GHIKITDF 155
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 81 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A +K + L +E R+L+ + +
Sbjct: 13 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 71
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R S + + +I+ L+YLH+ E
Sbjct: 72 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL N+ ++ + G +KI D
Sbjct: 129 KNVVYRDLKLENLMLDKD-GHIKITDF 154
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A +K + L +E R+L+ + +
Sbjct: 12 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 70
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R S + + +I+ L+YLH+ E
Sbjct: 71 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL N+ ++ + G +KI D
Sbjct: 128 KNVVYRDLKLENLMLDKD-GHIKITDF 153
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 19 LGGGQFGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 74 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADF 153
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 76/145 (52%), Gaps = 9/145 (6%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL-FSEVRLLKTLANKNIIS 90
L+G G+ V + +++ G VA +K DD M++++ E++LLK L ++N+++
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLKQLRHENLVN 88
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
L V + + R L F E L + + + ++K+ QI+ G+ + H+H
Sbjct: 89 LLEVCKKKKRWYLVF--EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRD+ N+ V+ +G VK+ D
Sbjct: 145 IIHRDIKPENILVS-QSGVVKLCDF 168
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 76 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9 PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
PS + + T TG YGR +K+ R D G + W ++ + + A
Sbjct: 2 PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69 MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
+ L SEV LL+ L + NI+ + D TL + E C G+L K+ ++
Sbjct: 48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + + + Q+ L H V+HRDL +NVF++G VK+GD
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9 PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
PS + + T TG YGR +K+ R D G + W ++ + + A
Sbjct: 2 PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69 MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
+ L SEV LL+ L + NI+ + D TL + E C G+L K+ ++
Sbjct: 48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + + + Q+ L H V+HRDL +NVF++G VK+GD
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 45/148 (30%), Positives = 65/148 (43%), Gaps = 19/148 (12%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
+ E+LG G + + +E G EV + +R D EV++++ L + N+
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETG-EVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNV 69
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS------KQILKGLN 142
+ V + R LNFITE G LR K S+ + WS K I G+
Sbjct: 70 LKFIGVLYKDKR--LNFITEYIKGGTLRGIIK-----SMDSQYPWSQRVSFAKDIASGMA 122
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQV 170
YLH+ +IHRDLN N V N V
Sbjct: 123 YLHSMN--IIHRDLNSHNCLVRENKNVV 148
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 22/174 (12%)
Query: 9 PSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA 68
PS + + T TG YGR +K+ R D G + W ++ + + A
Sbjct: 2 PSRAEDYEVLYTIGTGSYGR---------CQKIRRKSD---GKILVWKELDYGSMTE--A 47
Query: 69 MIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY----RKKHRH 124
+ L SEV LL+ L + NI+ + D TL + E C G+L K+ ++
Sbjct: 48 EKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY 107
Query: 125 VSVKALKKWSKQILKGLNYLHTHEP---CVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + + + Q+ L H V+HRDL +NVF++G VK+GD
Sbjct: 108 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDF 160
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 76 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 49.7 bits (117), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 19 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 73
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 74 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 130 FIHRDLAARNCLV-GENHLVKVADF 153
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 39/141 (27%), Positives = 63/141 (44%), Gaps = 5/141 (3%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G+ +V D+ G E A + R E L EV+LLK L + NI L
Sbjct: 33 VLGKGSFGEVILCKDKITGQECAVKVISKRQ-VKQKTDKESLLREVQLLKQLDHPNIXKL 91
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + ED+ + EV T G L + + S + +Q+L G+ Y H ++ +
Sbjct: 92 YEFF--EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK--I 147
Query: 152 IHRDLNCSNVFVNGNTGQVKI 172
+HRDL N+ + + I
Sbjct: 148 VHRDLKPENLLLESKSKDANI 168
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A +K + L +E R+L+ + +
Sbjct: 152 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 210
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R S + + +I+ L+YLH+ E
Sbjct: 211 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 267
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL N+ ++ + G +KI D
Sbjct: 268 KNVVYRDLKLENLMLDKD-GHIKITDF 293
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 49.3 bits (116), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A +K + L +E R+L+ + +
Sbjct: 155 YLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSRHPFL 213
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R S + + +I+ L+YLH+ E
Sbjct: 214 TALKYSFQTHDR--LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS-E 270
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL N+ ++ + G +KI D
Sbjct: 271 KNVVYRDLKLENLMLDKD-GHIKITDF 296
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LLG GA V A + G VA K+ F D P R E+++LK ++NII++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92 HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
+ R + N +I + +L HR +S + L + + Q L+ + L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
H VIHRDL SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY +L +GSGA V AFD GI VA ++ R F + +R + E+ LLK + +
Sbjct: 23 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF-QNQTHAKRAYRELVLLKCVNH 80
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLN 142
KNIISL V+ + TL +V L + + H + + + Q+L G+
Sbjct: 81 KNIISLLNVFTPQ--KTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 138
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 139 HLHS--AGIIHRDLKPSNIVVKSD 160
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LLG GA V A + G VA K+ F D P R E+++LK ++NII++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92 HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
+ R + N +I + +L HR +S + L + + Q L+ + L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
H VIHRDL SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 24 GRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK 81
G +Y +L +G G VY+A D + I VA +++L +D + E+ LLK
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLLK 74
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+SL V E L + E + + + +K + Q+L+G+
Sbjct: 75 ELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ H H ++HRDL N+ +N + G +K+ D
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLINSD-GALKLADF 163
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/142 (30%), Positives = 65/142 (45%), Gaps = 18/142 (12%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
LLG GA V A + G VA K+ F D P R E+++LK ++NII++
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIK--KIEPF-DKPLFALRTLREIKILKHFKHENIITI 74
Query: 92 HYVWRDEDRNTLN--FITEVCTSGNLREYRKKHRHVSVKAL-----KKWSKQILKGLNYL 144
+ R + N +I + +L HR +S + L + + Q L+ + L
Sbjct: 75 FNIQRPDSFENFNEVYIIQELMQTDL------HRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
H VIHRDL SN+ +N N
Sbjct: 129 HGSN--VIHRDLKPSNLLINSN 148
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 25 RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
+ G Y + LG G KV Q G +VA N+ K+R+ ++ ++ E++
Sbjct: 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL----DVVGKIKREIQN 64
Query: 80 LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
LK + +II L+ V + E + G L +Y KH V ++ +QIL
Sbjct: 65 LKLFRHPHIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++Y H H V+HRDL NV ++ + KI D
Sbjct: 123 AVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADF 155
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG G+ VY+A +E G VA QV + + ++ + E+ +++ + +++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD------LQEIIKEISIMQQCDSPHVVK 88
Query: 91 LHYVWRDEDRNT-LNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+ + +NT L + E C +G++ + R +++ ++ + + LKGL YLH
Sbjct: 89 YYGSYF---KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRD+ N+ +N G K+ D
Sbjct: 146 K--IHRDIKAGNILLN-TEGHAKLADF 169
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 79/160 (49%), Gaps = 18/160 (11%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY +L LG G V+ A D + VA ++ L DP ++ E+++++ L +
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDH 67
Query: 86 KNIISLHYVWR---DEDRNTLNFITEVCTSGNLREYRK-------KHRHVSVKALKKWSK 135
NI+ + + + + + +TE+ + ++EY + + + + + +
Sbjct: 68 DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+GL Y+H+ V+HRDL +N+F+N +KIGD
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDF 165
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 24 GRYGRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK 81
G +Y +L +G G VY+A D + I VA +++L +D + E+ LLK
Sbjct: 18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLD--AEDEGIPSTAIREISLLK 74
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+SL V E L + E + + + +K + Q+L+G+
Sbjct: 75 ELHHPNIVSLIDVIHSE--RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGV 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ H H ++HRDL N+ +N + G +K+ D
Sbjct: 133 AHCHQHR--ILHRDLKPQNLLINSD-GALKLADF 163
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
LG G+ KV A+ G +VA + K+ D IER S +RLL+ + +II
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 72
Query: 91 LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
L+ V + +D I + +GN L +Y + +S + +++ +QI+ + Y H H+
Sbjct: 73 LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 127
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL N+ ++ + VKI D
Sbjct: 128 -IVHRDLKPENLLLDEHL-NVKIADF 151
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 25 RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
+ G Y + LG G KV Q G +VA N+ K+R+ ++ ++ E++
Sbjct: 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSL----DVVGKIKREIQN 64
Query: 80 LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
LK + +II L+ V + E + G L +Y KH V ++ +QIL
Sbjct: 65 LKLFRHPHIIKLYQVISTP--TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++Y H H V+HRDL NV ++ + KI D
Sbjct: 123 AVDYCHRH--MVVHRDLKPENVLLDAHM-NAKIADF 155
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
LG G+ KV A+ G +VA + K+ D IER S +RLL+ + +II
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 78
Query: 91 LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
L+ V + +D I + +GN L +Y + +S + +++ +QI+ + Y H H+
Sbjct: 79 LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 133
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL N+ ++ + VKI D
Sbjct: 134 -IVHRDLKPENLLLDEHL-NVKIADF 157
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
LG G+ KV A+ G +VA + K+ D IER S +RLL+ + +II
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 68
Query: 91 LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
L+ V + +D I + +GN L +Y + +S + +++ +QI+ + Y H H+
Sbjct: 69 LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 123
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL N+ ++ + VKI D
Sbjct: 124 -IVHRDLKPENLLLDEHL-NVKIADF 147
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/144 (32%), Positives = 72/144 (50%), Gaps = 11/144 (7%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY +L +GSGA V AFD GI VA ++ R F + +R + E+ LLK + +
Sbjct: 25 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-RPF-QNQTHAKRAYRELVLLKCVNH 82
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY---RKKHRHVSVKALKKWSKQILKGLN 142
KNIISL V+ + TL +V L + + H + + + Q+L G+
Sbjct: 83 KNIISLLNVFTPQ--KTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIK 140
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 141 HLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 14/156 (8%)
Query: 25 RYGRY--NELLGSGAVKKVYRAFDQEEGIEVA---WNQVKLRTFCDDPAMIERLFSEVRL 79
+ G Y + LG G KV + G +VA N+ K+R+ ++ ++ E++
Sbjct: 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSL----DVVGKIRREIQN 69
Query: 80 LKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILK 139
LK + +II L+ V + + + E + G L +Y K+ + K ++ +QIL
Sbjct: 70 LKLFRHPHIIKLYQVISTP--SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127
Query: 140 GLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
G++Y H H V+HRDL NV ++ + KI D
Sbjct: 128 GVDYCHRH--MVVHRDLKPENVLLDAHMN-AKIADF 160
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 48.9 bits (115), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 74/146 (50%), Gaps = 13/146 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQV--KLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
LG G+ KV A+ G +VA + K+ D IER S +RLL+ + +II
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR---HPHIIK 77
Query: 91 LHYVWRDEDRNTLNFITEVCTSGN-LREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
L+ V + +D I + +GN L +Y + +S + +++ +QI+ + Y H H+
Sbjct: 78 LYDVIKSKDE----IIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK- 132
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL N+ ++ + VKI D
Sbjct: 133 -IVHRDLKPENLLLDEHL-NVKIADF 156
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 13/165 (7%)
Query: 14 SEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERL 73
+E F + DP + E+ G G+ VY A D VA ++ + + +
Sbjct: 5 AELFFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW-QDI 62
Query: 74 FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVC---TSGNLREYRKKHRHVSVKAL 130
EVR L+ L + N I + E +T + E C S L ++K + V + A+
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAV 120
Query: 131 KKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L+GL YLH+H +IHRD+ N+ ++ G VK+GD
Sbjct: 121 ---THGALQGLAYLHSHN--MIHRDVKAGNILLS-EPGLVKLGDF 159
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 81 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 25 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 79
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 80 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 135
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 136 FIHRDLAARNCLV-GENHLVKVADF 159
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 81 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 48.5 bits (114), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/139 (26%), Positives = 69/139 (49%), Gaps = 13/139 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G+G+ V+RA + G +VA + + F + + EV ++K L + NI+
Sbjct: 43 EKIGAGSFGTVHRA--EWHGSDVAVKILMEQDFHAE--RVNEFLREVAIMKRLRHPNIVL 98
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKK-----WSKQILKGLNYLH 145
++ L+ +TE + G+L YR H+ + + L + + + KG+NYLH
Sbjct: 99 --FMGAVTQPPNLSIVTEYLSRGSL--YRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 146 THEPCVIHRDLNCSNVFVN 164
P ++HR+L N+ V+
Sbjct: 155 NRNPPIVHRNLKSPNLLVD 173
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +G GA V A+D + VA ++ + + +R E+++L +
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI---SPFEHQTYXQRTLREIKILLRFRH 84
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRK-KHRHVSVKALKKWSKQILKGL 141
+NII ++ + R T+ + +V +L E Y+ K +H+S + + QIL+GL
Sbjct: 85 ENIIGINDIIRAP---TIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ V+HRDL SN+ +N T +KI D
Sbjct: 142 KYIHSAN--VLHRDLKPSNLLLN-TTXDLKICDF 172
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA KVY+A ++E G A ++ ++ + +E E+ +L T + I+ L
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 74
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + + L + E C G + + R ++ ++ +Q+L+ LN+LH+ +
Sbjct: 75 GAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 130
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL NV + G +++ D
Sbjct: 131 IHRDLKAGNVLMTLE-GDIRLADF 153
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 76 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 76
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 77 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 132
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 133 FIHRDLAARNCLV-GENHLVKVADF 156
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 48.1 bits (113), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 75
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 76 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 131
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 132 FIHRDLAARNCLV-GENHLVKVADF 155
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 81 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 137 FIHRDLAARNCLV-GENHLVKVADF 160
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 78 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 37/144 (25%), Positives = 70/144 (48%), Gaps = 10/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA KVY+A ++E G A ++ ++ + +E E+ +L T + I+ L
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEE----LEDYIVEIEILATCDHPYIVKLL 82
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYR-KKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
+ + + L + E C G + + R ++ ++ +Q+L+ LN+LH+ +
Sbjct: 83 GAYYHDGK--LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR--I 138
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL NV + G +++ D
Sbjct: 139 IHRDLKAGNVLMTLE-GDIRLADF 161
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 78 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 88
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 89 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 145 FIHRDLAARNCLV-GENHLVKVADF 168
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 48.1 bits (113), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 77
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 78 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 133
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N V G VK+ D
Sbjct: 134 FIHRDLAARNCLV-GENHLVKVADF 157
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + VS L + QI + YL
Sbjct: 283 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN-- 338
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHR+L N V G VK+ D
Sbjct: 339 FIHRNLAARNCLV-GENHLVKVADF 362
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 11/147 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A+D +VA ++ R F R + E+RLLK L ++N+I L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93 YVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
V+ ED + + +T +L K + +S + ++ Q+L+GL Y+H+
Sbjct: 94 DVFTPATSIEDFSEVYLVT-TLMGADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHS-- 149
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL SNV VN ++ +++I D
Sbjct: 150 AGIIHRDLKPSNVAVNEDS-ELRILDF 175
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 47.8 bits (112), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 71 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 47.4 bits (111), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII H + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNII--HLLGACTQDGPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 71 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 71 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 71 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 70
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 71 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 127
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 128 HRDVKPSNILVN-SRGEIKLCDF 149
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 36/144 (25%), Positives = 71/144 (49%), Gaps = 9/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 76 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 132
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCV 151
+ + ++ E G+L + KK + + L K S ++KGL YL H+ +
Sbjct: 133 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 188
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
+HRD+ SN+ VN + G++K+ D
Sbjct: 189 MHRDVKPSNILVN-SRGEIKLCDF 211
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 47.4 bits (111), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 76 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 76 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 75
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 76 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 131
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 132 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 161
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 17 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 73
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 74 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 130
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 131 HRDVKPSNILVN-SRGEIKLCDF 152
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 36/190 (18%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQE---EGIEVAWNQVKLRT 62
SE + DP + R + LG GA +V A D++ E + VA +K
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 63 FCDDPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKK 121
+D + L SE+ ++K + +KNII+L + L I E + GNLREY +
Sbjct: 80 TEED---LSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRA 134
Query: 122 HR----------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNG 165
R ++ K L + Q+ +G+ YL + + IHRDL NV V
Sbjct: 135 RRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTE 192
Query: 166 NTGQVKIGDL 175
N +KI D
Sbjct: 193 NN-VMKIADF 201
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 47.4 bits (111), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 24 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 81
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 82 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 137
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 138 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 167
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G +V+ + +V ++T ++ E L+KTL + ++ L+
Sbjct: 20 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 73
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
V E+ + ITE G+L ++ K V + L +S QI +G+ Y+
Sbjct: 74 AVVTKEE--PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 129
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +NV V+ + KI D
Sbjct: 130 YIHRDLRAANVLVS-ESLMCKIADF 153
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 52/187 (27%), Positives = 79/187 (42%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 47.0 bits (110), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 17 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 74
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 75 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 130
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 131 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 160
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 38/146 (26%), Positives = 66/146 (45%), Gaps = 7/146 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR 78
+ D +Y +E +G+G KV A G VA + T D + R+ +E+
Sbjct: 4 DYDELLKYYELHETIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSD---LPRIKTEIE 60
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
LK L +++I L++V E N + + E C G L +Y +S + + +QI+
Sbjct: 61 ALKNLRHQHICQLYHVL--ETANKIFMVLEYCPGGELFDYIISQDRLSEEETRVVFRQIV 118
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
+ Y+H+ HRDL N+ +
Sbjct: 119 SAVAYVHSQG--YAHRDLKPENLLFD 142
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 98 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 154
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 155 HRDVKPSNILVN-SRGEIKLCDF 176
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 47.0 bits (110), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 68 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 12 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 70
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 71 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 129 --VVYRDIKLENLMLDKD-GHIKITDF 152
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 68 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 68 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 47.0 bits (110), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 200
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 201 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 256
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 257 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 286
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 15/151 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFC------DDPAMIERLFSEVRLLKTLANK 86
LGSGA +V AF+++ +VA + R F DPA+ + +E+ +LK L +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL--NVETEIEILKKLNHP 214
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
II + + ED + E+ G L + ++ + K + Q+L + YLH
Sbjct: 215 CIIKIKNFFDAED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH- 270
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQ--VKIGDL 175
E +IHRDL NV ++ +KI D
Sbjct: 271 -ENGIIHRDLKPENVLLSSQEEDCLIKITDF 300
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 46.6 bits (109), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 11/147 (7%)
Query: 31 ELLGS-GAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
E++G G KVY+A ++E + A + ++ +E E+ +L + + NI+
Sbjct: 15 EIIGELGDFGKVYKAQNKETSVLAAAKVIDTKS----EEELEDYMVEIDILASCDHPNIV 70
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKK-HRHVSVKALKKWSKQILKGLNYLHTHE 148
L + E N L + E C G + + R ++ ++ KQ L LNYLH ++
Sbjct: 71 KLLDAFYYE--NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ + G +K+ D
Sbjct: 129 --IIHRDLKAGNILFTLD-GDIKLADF 152
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 84/164 (51%), Gaps = 20/164 (12%)
Query: 21 DPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLL 80
DP G + EL+G+G +VY+ + G A +K+ D E + E+ +L
Sbjct: 21 DPAGIF-ELVELVGNGTYGQVYKGRHVKTGQLAA---IKVMDVTGDEE--EEIKQEINML 74
Query: 81 KTLAN-KNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRHVSVKALKKW-- 133
K ++ +NI + + + ++ ++ + E C +G++ + K + ++K ++W
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK--EEWIA 132
Query: 134 --SKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++IL+GL++LH H+ VIHRD+ NV + N +VK+ D
Sbjct: 133 YICREILRGLSHLHQHK--VIHRDIKGQNVLLTEN-AEVKLVDF 173
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 23 TGRYGRYNEL------LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSE 76
T + G +E+ LGSGA +V D+ +E A ++ + +L E
Sbjct: 29 TSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSN--SKLLEE 86
Query: 77 VRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE---YRKKHRHVSVKALKKW 133
V +LK L + NI+ L+ + ED+ + E G L + +R K V +
Sbjct: 87 VAVLKLLDHPNIMKLYDFF--EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI--- 141
Query: 134 SKQILKGLNYLHTHEPCVIHRDLNCSNVFV 163
KQ+L G+ YLH H ++HRDL N+ +
Sbjct: 142 IKQVLSGVTYLHKHN--IVHRDLKPENLLL 169
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 68 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A D+ G +VA ++ R F + +R + E+ LLK + ++N+I L
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSE-IFAKRAYRELLLLKHMQHENVIGLL 107
Query: 93 YVWRDED--RNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
V+ RN +F + +L++ S + ++ Q+LKGL Y+H+
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS--A 163
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ VN + ++KI D
Sbjct: 164 GVVHRDLKPGNLAVNEDC-ELKILDF 188
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V++ + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 33 LGAGNGGVVFKVSHKPSGLVMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 89
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ + ++ E G+L + KK + + L K S ++KGL YL ++
Sbjct: 90 GAFYSD--GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK-IM 146
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ SN+ VN + G++K+ D
Sbjct: 147 HRDVKPSNILVN-SRGEIKLCDF 168
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/171 (25%), Positives = 78/171 (45%), Gaps = 20/171 (11%)
Query: 16 PFIETDPTGRYGRYN--------ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
PF T + G N E+LG G +V++ + G+++A +K R D
Sbjct: 72 PFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK- 130
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSV 127
E + +E+ ++ L + N+I L+ + E +N + + E G L + R ++
Sbjct: 131 ---EEVKNEISVMNQLDHANLIQLYDAF--ESKNDIVLVMEYVDGGELFD-RIIDESYNL 184
Query: 128 KALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVF-VNGNTGQVKIGDL 175
L + KQI +G+ H H+ ++H DL N+ VN + Q+KI D
Sbjct: 185 TELDTILFMKQICEGIR--HMHQMYILHLDLKPENILCVNRDAKQIKIIDF 233
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 14 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 72
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 73 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 131 --VVYRDIKLENLMLDKD-GHIKITDF 154
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+E LG+GA V+R ++ G A V D E + E++ + L + ++
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLV 217
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+LH + ED N + I E + G L E +H +S ++ +Q+ KGL H HE
Sbjct: 218 NLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHE 273
Query: 149 PCVIHRDLNCSNV-FVNGNTGQVKIGDL 175
+H DL N+ F + ++K+ D
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDF 301
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 10/148 (6%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+E LG+GA V+R ++ G A V D E + E++ + L + ++
Sbjct: 56 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK----ETVRKEIQTMSVLRHPTLV 111
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+LH + ED N + I E + G L E +H +S ++ +Q+ KGL H HE
Sbjct: 112 NLHDAF--EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGL--CHMHE 167
Query: 149 PCVIHRDLNCSNV-FVNGNTGQVKIGDL 175
+H DL N+ F + ++K+ D
Sbjct: 168 NNYVHLDLKPENIMFTTKRSNELKLIDF 195
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 46/149 (30%), Positives = 78/149 (52%), Gaps = 15/149 (10%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A+D +VA ++ R F R + E+RLLK L ++N+I L
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 93 YVWRD----EDRNTLNFITEVCTS--GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
V+ ED + + +T + + N+ K + +S + ++ Q+L+GL Y+H+
Sbjct: 94 DVFTPATSIEDFSEVYLVTTLMGADLNNI----VKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL SNV VN ++ +++I D
Sbjct: 150 --AGIIHRDLKPSNVAVNEDS-ELRILDF 175
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 46.6 bits (109), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 49/178 (27%), Positives = 75/178 (42%), Gaps = 29/178 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN 193
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 6/147 (4%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
Y +LLG G KV ++ G A ++ + +E R+L+ + +
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDE-VAHTVTESRVLQNTRHPFL 67
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+L Y ++ DR L F+ E G L + + R + + + + +I+ L YLH+ +
Sbjct: 68 TALKYAFQTHDR--LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RD+ N+ ++ + G +KI D
Sbjct: 126 --VVYRDIKLENLMLDKD-GHIKITDF 149
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 9/147 (6%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
L+G G+ VY A+D+ VA +V R F +D +R+ E+ +L L + II L
Sbjct: 35 LIGRGSYGYVYLAYDKNANKNVAIKKVN-RMF-EDLIDCKRILREITILNRLKSDYIIRL 92
Query: 92 HYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
H + ED + L + E+ S +L++ K ++ + +K +L G ++H E
Sbjct: 93 HDLIIPEDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH--E 149
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N +N + VKI D
Sbjct: 150 SGIIHRDLKPANCLLNQDCS-VKICDF 175
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 46.2 bits (108), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 16/158 (10%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NK 86
R +L G VY A D G E A R ++ + EV +K L+ +
Sbjct: 31 RVRRVLAEGGFAFVYEAQDVGSGREYALK----RLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 87 NII---SLHYVWRDE-DRNTLNFI--TEVCTSGNLREYRKKHRH---VSVKALKKWSKQI 137
NI+ S + ++E D F+ TE+C G L E+ KK +S + K Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + ++H +P +IHRDL N+ ++ N G +K+ D
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDF 182
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G +V+ A + +V ++T +E +E ++KTL + ++ LH
Sbjct: 23 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
V E + ITE G+L ++ K + L +S QI +G+ ++
Sbjct: 77 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 131
Query: 151 VIHRDLNCSNVFVNGN 166
IHRDL +N+ V+ +
Sbjct: 132 YIHRDLRAANILVSAS 147
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G +V+ A + +V ++T +E +E ++KTL + ++ LH
Sbjct: 196 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
V E + ITE G+L ++ K + L +S QI +G+ ++
Sbjct: 250 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 304
Query: 151 VIHRDLNCSNVFVNGN 166
IHRDL +N+ V+ +
Sbjct: 305 YIHRDLRAANILVSAS 320
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 38/145 (26%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G +V+ + +V ++T ++ E L+KTL + ++ L+
Sbjct: 21 LGAGQFGEVWMGYYNNS------TKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLY 74
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
V E+ + ITE G+L ++ K V + L +S QI +G+ Y+
Sbjct: 75 AVVTREE--PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN-- 130
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +NV V+ + KI D
Sbjct: 131 YIHRDLRAANVLVS-ESLMCKIADF 154
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 34/136 (25%), Positives = 62/136 (45%), Gaps = 13/136 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G +V+ A + +V ++T +E +E ++KTL + ++ LH
Sbjct: 190 LGAGQFGEVWMATYNKH------TKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHR--HVSVKALKKWSKQILKGLNYLHTHEPC 150
V E + ITE G+L ++ K + L +S QI +G+ ++
Sbjct: 244 AVVTKE---PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN-- 298
Query: 151 VIHRDLNCSNVFVNGN 166
IHRDL +N+ V+ +
Sbjct: 299 YIHRDLRAANILVSAS 314
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 279
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 280 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 335
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHR+L N V G VK+ D
Sbjct: 336 FIHRNLAARNCLV-GENHLVKVADF 359
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G+ +V+R D++ G + A +V+L F +E L + L++ I+ L+
Sbjct: 80 LGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 130
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
R+ +N E+ G+L + K+ + + Q L+GL YLHT ++
Sbjct: 131 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 186
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
H D+ NV ++ + + + D
Sbjct: 187 HGDVKADNVLLSSDGSRAALCDF 209
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 24/106 (22%), Positives = 60/106 (56%), Gaps = 5/106 (4%)
Query: 70 IERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA 129
+ +F E+++++ L + +++L Y ++DE+ + + ++ G+LR + +++ H +
Sbjct: 59 VRNVFKELQIMQGLEHPFLVNLWYSFQDEE--DMFMVVDLLLGGDLRYHLQQNVHFKEET 116
Query: 130 LKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+K + +++ L+YL +IHRD+ N+ ++ + G V I D
Sbjct: 117 VKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEH-GHVHITDF 159
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG G +V A D+++ E VK+
Sbjct: 7 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 66
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 67 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 124
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 125 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLTARNVLVTENN- 181
Query: 169 QVKIGDL 175
+KI D
Sbjct: 182 VMKIADF 188
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
P + T G + E LG+G V R Q+ G +VA Q + P ER
Sbjct: 6 PSLPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCL 61
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRH---VSVK 128
E++++K L + N++S V + N E C G+LR+Y + + +
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV--KIGDL 175
++ I L YLH + +IHRDL N+ + ++ KI DL
Sbjct: 122 PIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 168
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 40/145 (27%), Positives = 63/145 (43%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G +VY ++ + VA ++T +D +E E ++K + + N++ L
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVA-----VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 321
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKK--HRHVSVKALKKWSKQILKGLNYLHTHEPC 150
V E ITE T GNL +Y ++ + V+ L + QI + YL
Sbjct: 322 GVCTREP--PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN-- 377
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHR+L N V G VK+ D
Sbjct: 378 FIHRNLAARNCLV-GENHLVKVADF 401
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
P + T G + E LG+G V R Q+ G +VA Q + P ER
Sbjct: 7 PSLPTQTCGPW-EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL---SPKNRERWCL 62
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLN----FITEVCTSGNLREYRKKHRH---VSVK 128
E++++K L + N++S V + N E C G+LR+Y + + +
Sbjct: 63 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 122
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQV--KIGDL 175
++ I L YLH + +IHRDL N+ + ++ KI DL
Sbjct: 123 PIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIHKIIDL 169
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
++ LH ++ E R L F+ E G+L + ++ R + + + +S +I LNYL H
Sbjct: 115 LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 170
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
E +I+RDL NV ++ + G +K+ D
Sbjct: 171 ERGIIYRDLKLDNVLLD-SEGHIKLTD 196
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 74/146 (50%), Gaps = 10/146 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A D+ G +VA ++ R F + +R + E+ LLK + ++N+I L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQSE-IFAKRAYRELLLLKHMQHENVIGLL 89
Query: 93 YVWRDED--RNTLNF-ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
V+ RN +F + +L++ S + ++ Q+LKGL Y+H+
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHS--A 145
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRDL N+ VN + ++KI D
Sbjct: 146 GVVHRDLKPGNLAVNEDC-ELKILDF 170
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/138 (31%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+GSGA V A+D +VA ++ R F R + E+RLLK L ++N+I L
Sbjct: 28 VGSGAYGSVCSAYDARLRQKVAVKKLS-RPF-QSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 93 YVWRD----EDRNTLNFITEVCTS--GNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
V+ ED + + +T + + N+ K + +S + ++ Q+L+GL Y+H+
Sbjct: 86 DVFTPATSIEDFSEVYLVTTLMGADLNNI----VKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 147 HEPCVIHRDLNCSNVFVN 164
+IHRDL SNV VN
Sbjct: 142 --AGIIHRDLKPSNVAVN 157
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 45.8 bits (107), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY A +++ +A +V ++ + + +L E+ + L + NI+ ++
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 81
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ DR + + E G L + +KH + + +++ L+Y HE VI
Sbjct: 82 NYF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 137
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ N+ + G G++KI D
Sbjct: 138 HRDIKPENLLM-GYKGELKIADF 159
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
++ LH ++ E R L F+ E G+L + ++ R + + + +S +I LNYL H
Sbjct: 83 LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 138
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
E +I+RDL NV ++ + G +K+ D
Sbjct: 139 ERGIIYRDLKLDNVLLD-SEGHIKLTD 164
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY A +++ +A +V ++ + + +L E+ + L + NI+ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ DR + + E G L + +KH + + +++ L+Y HE VI
Sbjct: 81 NYF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 136
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ N+ + G G++KI D
Sbjct: 137 HRDIKPENLLM-GYKGELKIADF 158
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG G +V A D+++ E VK+
Sbjct: 66 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 125
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 183
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 184 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTEN-N 240
Query: 169 QVKIGDL 175
+KI D
Sbjct: 241 VMKIADF 247
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
++ LH ++ E R L F+ E G+L + ++ R + + + +S +I LNYL H
Sbjct: 68 LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 123
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
E +I+RDL NV ++ + G +K+ D
Sbjct: 124 ERGIIYRDLKLDNVLLD-SEGHIKLTD 149
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 27/87 (31%), Positives = 48/87 (55%), Gaps = 5/87 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
++ LH ++ E R L F+ E G+L + ++ R + + + +S +I LNYL H
Sbjct: 72 LVGLHSCFQTESR--LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL--H 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGD 174
E +I+RDL NV ++ + G +K+ D
Sbjct: 128 ERGIIYRDLKLDNVLLD-SEGHIKLTD 153
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 35/143 (24%), Positives = 67/143 (46%), Gaps = 6/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY A +++ +A +V ++ + + +L E+ + L + NI+ ++
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMAL-KVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ DR + + E G L + +KH + + +++ L+Y HE VI
Sbjct: 81 NYF--HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHY--CHERKVI 136
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ N+ + G G++KI D
Sbjct: 137 HRDIKPENLLM-GYKGELKIADF 158
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 45.4 bits (106), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 24/158 (15%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG GA +V +A + + A +++ + + SEV LL +L ++ ++
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 92 HYVWRD-----------EDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALKKWS--KQI 137
+ W + + ++TL E C +G L Y H +++ + + W +QI
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL--YDLIHSENLNQQRDEYWRLFRQI 125
Query: 138 LKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L+ L+Y+H+ +IHRDL N+F++ + VKIGD
Sbjct: 126 LEALSYIHSQ--GIIHRDLKPMNIFID-ESRNVKIGDF 160
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG G +V A D+++ E VK+
Sbjct: 9 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 68
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 69 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 126
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 127 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 183
Query: 169 QVKIGDL 175
+KI D
Sbjct: 184 VMKIADF 190
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG G +V A D+++ E VK+
Sbjct: 12 SEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 71
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I E + GNLREY + R
Sbjct: 72 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVEYASKGNLREYLRARRP 129
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 130 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 186
Query: 169 QVKIGDL 175
+KI D
Sbjct: 187 VMKIADF 193
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 11/152 (7%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAM-IERLFSEVRLLKTLANKNII 89
E++G GA V R ++E G + A V + F P + E L E + L + +I+
Sbjct: 30 EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNL---REYRKKHRHVSVKALKK-WSKQILKGLNYLH 145
L + + L + E +L R V +A+ + +QIL+ L Y H
Sbjct: 90 ELLETYSSD--GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 146 THEPCVIHRDLNCSNVFVNG--NTGQVKIGDL 175
+ +IHRD+ NV + N+ VK+GD
Sbjct: 148 DNN--IIHRDVKPENVLLASKENSAPVKLGDF 177
>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|B Chain B, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|C Chain C, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2VX3|D Chain D, Crystal Structure Of The Human Dual Specificity Tyrosine-
Phosphorylation-Regulated Kinase 1a
pdb|2WO6|A Chain A, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
pdb|2WO6|B Chain B, Human Dual-Specificity Tyrosine-Phosphorylation-Regulated
Kinase 1a In Complex With A Consensus Substrate Peptide
Length = 382
Score = 45.4 bits (106), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+ L+G G+ +V +A+D+ +E W V ++ + A + + EVRLL+ L NK+
Sbjct: 59 DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 112
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
+ Y R+ + F +C + Y R VS+ +K+++Q+ L
Sbjct: 113 EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
+L T E +IH DL N+ + N +KI D
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G+ +V+R D++ G + A +V+L F + E+ L + I+ L+
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 151
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
R+ +N E+ G+L + K+ + + Q L+GL YLH+ ++
Sbjct: 152 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 207
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
H D+ NV ++ + + D
Sbjct: 208 HGDVKADNVLLSSDGSHAALCDF 230
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 33/143 (23%), Positives = 63/143 (44%), Gaps = 13/143 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G+ +V+R D++ G + A +V+L F + E+ L + I+ L+
Sbjct: 82 LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFRAE---------ELMACAGLTSPRIVPLY 132
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
R+ +N E+ G+L + K+ + + Q L+GL YLH+ ++
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR--IL 188
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
H D+ NV ++ + + D
Sbjct: 189 HGDVKADNVLLSSDGSHAALCDF 211
>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|B Chain B, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|C Chain C, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANQ|D Chain D, Human Dyrk1aINHIBITOR COMPLEX
pdb|3ANR|A Chain A, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|B Chain B, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|C Chain C, Human Dyrk1aHARMINE COMPLEX
pdb|3ANR|D Chain D, Human Dyrk1aHARMINE COMPLEX
Length = 368
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+ L+G G+ +V +A+D+ +E W V ++ + A + + EVRLL+ L NK+
Sbjct: 40 DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 93
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
+ Y R+ + F +C + Y R VS+ +K+++Q+ L
Sbjct: 94 EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 152
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
+L T E +IH DL N+ + N +KI D
Sbjct: 153 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 186
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVAYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 96 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 45.1 bits (105), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 96 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 45.1 bits (105), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 96 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 89 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 147 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 187
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 137 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 195 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 235
>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|B Chain B, Human Dyrk1a In Complex With Leucettine L41
pdb|4AZE|C Chain C, Human Dyrk1a In Complex With Leucettine L41
Length = 382
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+ L+G G+ +V +A+D+ +E W V ++ + A + + EVRLL+ L NK+
Sbjct: 59 DSLIGKGSFGQVVKAYDR---VEQEW--VAIKIIKNKKAFLNQAQIEVRLLE-LMNKHDT 112
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSKQILKGLN 142
+ Y R+ + F +C + Y R VS+ +K+++Q+ L
Sbjct: 113 EMKYYIVHLKRHFM-FRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALL 171
Query: 143 YLHTHEPCVIHRDLNCSNVFV-NGNTGQVKIGDL 175
+L T E +IH DL N+ + N +KI D
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRXAIKIVDF 205
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 78/187 (41%), Gaps = 30/187 (16%)
Query: 14 SEPFIETDPTGRYGR----YNELLGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCD 65
SE + DP + R + LG GA +V A D+++ E VK+
Sbjct: 20 SEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA 79
Query: 66 DPAMIERLFSEVRLLKTLA-NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR- 123
+ L SE+ ++K + +KNII+L + L I + GNLREY + R
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD--GPLYVIVGYASKGNLREYLRARRP 137
Query: 124 ---------------HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
++ K L + Q+ +G+ YL + + IHRDL NV V N
Sbjct: 138 PGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVTENN- 194
Query: 169 QVKIGDL 175
+KI D
Sbjct: 195 VMKIADF 201
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 81 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLV 138
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 139 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 179
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 88 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 146 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 186
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSVKALK 131
II+L + L I E + GNLREY + R +S K L
Sbjct: 85 IINLLGACTQD--GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 142
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 143 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 183
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ +V+R D++ G + A +V+L F +E L + L++ I+ L+
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 116
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
R+ +N E+ G+L + K+ + + Q L+GL YLHT ++
Sbjct: 117 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 172
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
H D+ NV ++ + + + D
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDF 195
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A G A +++L +D + E+ +LK L + NI+
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91 LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L+ V + R L F + +VC G SV A K + Q+L G+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y H V+HRDL N+ +N G++KI D
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A G A +++L +D + E+ +LK L + NI+
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91 LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L+ V + R L F + +VC G SV A K + Q+L G+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y H V+HRDL N+ +N G++KI D
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 64/148 (43%), Gaps = 10/148 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNII 89
E LG GA V R + E A + + D +ER E R+ + L + NI+
Sbjct: 37 EELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIV 93
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
LH +E + L F ++ T G L E + S QIL+ +N++H H+
Sbjct: 94 RLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHD- 150
Query: 150 CVIHRDLNCSNVFVNGNT--GQVKIGDL 175
++HRDL N+ + VK+ D
Sbjct: 151 -IVHRDLKPENLLLASKCKGAAVKLADF 177
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 26/154 (16%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E +G G VY+A G A +++L +D + E+ +LK L + NI+
Sbjct: 8 EKIGEGTYGVVYKA-QNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVK 64
Query: 91 LHYVWRDEDRNTLNF---------ITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L+ V + R L F + +VC G SV A K + Q+L G+
Sbjct: 65 LYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG----------LESVTA-KSFLLQLLNGI 113
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y H V+HRDL N+ +N G++KI D
Sbjct: 114 AYCHDRR--VLHRDLKPQNLLIN-REGELKIADF 144
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 44.7 bits (104), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 34/143 (23%), Positives = 66/143 (46%), Gaps = 13/143 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ +V+R D++ G + A +V+L F +E L + L++ I+ L+
Sbjct: 82 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVA----CAGLSSPRIVPLY 132
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
R+ +N E+ G+L + K+ + + Q L+GL YLHT ++
Sbjct: 133 GAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR--IL 188
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
H D+ NV ++ + + + D
Sbjct: 189 HGDVKADNVLLSSDGSRAALCDF 211
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 44.7 bits (104), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
E++GSGA V A+ + +VA ++ L C ++ L E++ + + NI+
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQ--TSMDELLKEIQAMSQCHHPNIV 76
Query: 90 SLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----------KQ 136
S + +V +DE L + ++ + G++ + K H+ K K ++
Sbjct: 77 SYYTSFVVKDE----LWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILRE 129
Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+L+GL YLH + IHRD+ N+ + G G V+I D
Sbjct: 130 VLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADF 165
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 26/159 (16%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
E++GSGA V A+ + +VA ++ L C ++ L E++ + + NI+
Sbjct: 15 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQ--TSMDELLKEIQAMSQCHHPNIV 71
Query: 90 SLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----------KQ 136
S + +V +DE L + ++ + G++ + K H+ K K ++
Sbjct: 72 SYYTSFVVKDE----LWLVMKLLSGGSVLDIIK---HIVAKGEHKSGVLDESTIATILRE 124
Query: 137 ILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+L+GL YLH + IHRD+ N+ + G G V+I D
Sbjct: 125 VLEGLEYLHKNGQ--IHRDVKAGNILL-GEDGSVQIADF 160
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 68/145 (46%), Gaps = 12/145 (8%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG GA VYR +++G + + L+ D + + +E+ +L L++ NII L
Sbjct: 61 LGRGATSIVYRC--KQKGTQKPYALKVLKKTVDK----KIVRTEIGVLLRLSHPNIIKLK 114
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
++ E ++ + E+ T G L + + + S + KQIL+ + YL HE ++
Sbjct: 115 EIF--ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYL--HENGIV 170
Query: 153 HRDLNCSNVF--VNGNTGQVKIGDL 175
HRDL N+ +KI D
Sbjct: 171 HRDLKPENLLYATPAPDAPLKIADF 195
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQV-------KLRTFCDDPAMIERLFSEVRLLKTLA 84
+ SG+ V D E GI VA +V + D + +R+ E+RLL
Sbjct: 29 FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 85 NKNIISLHYVW---RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+ NI+ L ++ + + L +TE+ + + + +S + ++ + IL GL
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+ LH E V+HRDL+ N+ + N
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN 170
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 30/153 (19%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWN---QVKLRTFCDD-PAMIERLFSEVRLLKTLANKNI 88
+GSG+ VY+ W+ VK+ D P + +EV +L+ + NI
Sbjct: 44 IGSGSFGTVYKG---------KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNI 94
Query: 89 I-SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKW-----SKQILKGLN 142
+ + Y+ +D L +T+ C +L KH HV + + ++Q +G++
Sbjct: 95 LLFMGYMTKD----NLAIVTQWCEGSSLY----KHLHVQETKFQMFQLIDIARQTAQGMD 146
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
YLH +IHRD+ +N+F++ VKIGD
Sbjct: 147 YLHAKN--IIHRDMKSNNIFLHEGL-TVKIGDF 176
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 44.3 bits (103), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 35/144 (24%), Positives = 71/144 (49%), Gaps = 9/144 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG+G V + + G+ +A + L PA+ ++ E+++L + I+ +
Sbjct: 24 LGAGNGGVVTKVQHRPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECNSPYIVGFY 80
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYL-HTHEPCV 151
+ + ++ E G+L + K+ + + + L K S +L+GL YL H+ +
Sbjct: 81 GAFYSD--GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ--I 136
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
+HRD+ SN+ VN + G++K+ D
Sbjct: 137 MHRDVKPSNILVN-SRGEIKLCDF 159
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 44.3 bits (103), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 37/145 (25%), Positives = 66/145 (45%), Gaps = 13/145 (8%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQV-------KLRTFCDDPAMIERLFSEVRLLKTLA 84
+ SG+ V D E GI VA +V + D + +R+ E+RLL
Sbjct: 29 FISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 85 NKNIISLHYVW---RDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
+ NI+ L ++ + + L +TE+ + + + +S + ++ + IL GL
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+ LH E V+HRDL+ N+ + N
Sbjct: 148 HVLH--EAGVVHRDLHPGNILLADN 170
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 43.9 bits (102), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ + Y + D+ L+FI ++ G+L + +H S ++ ++ +I+ GL H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 63/148 (42%), Gaps = 10/148 (6%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLKTLANKNII 89
E LG GA V R G E A + + D +ER E R+ + L + NI+
Sbjct: 28 EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARICRLLKHPNIV 84
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
LH +E + L F ++ T G L E + S +QIL+ + LH H+
Sbjct: 85 RLHDSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV--LHCHQM 140
Query: 150 CVIHRDLNCSNVFVNGNT--GQVKIGDL 175
V+HRDL N+ + VK+ D
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADF 168
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ + Y + D+ L+FI ++ G+L + +H S ++ ++ +I+ GL H H
Sbjct: 253 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 308
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL +N+ ++ + G V+I DL
Sbjct: 309 NRFVVYRDLKPANILLDEH-GHVRISDL 335
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ + Y + D+ L+FI ++ G+L + +H S ++ ++ +I+ GL H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 25/88 (28%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ + Y + D+ L+FI ++ G+L + +H S ++ ++ +I+ GL H H
Sbjct: 254 IVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE--HMH 309
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V++RDL +N+ ++ + G V+I DL
Sbjct: 310 NRFVVYRDLKPANILLDEH-GHVRISDL 336
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 43.9 bits (102), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG GA V R + G+E A + + ++L E R+ + L + NI+
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD--FQKLEREARICRKLQHPNIVR 92
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH ++E + L F ++ T G L E S +QIL+ + Y H++
Sbjct: 93 LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 148
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
++HR+L N+ + VK+ D
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADF 175
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 43.9 bits (102), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 39/145 (26%), Positives = 67/145 (46%), Gaps = 7/145 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS- 90
+LG G+ KV A +E G A +K D +E +E R+L N ++
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDD-VECTMTEKRILSLARNHPFLTQ 88
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
L ++ DR L F+ E G+L + +K R + ++ +I+ L +L H+
Sbjct: 89 LFCCFQTPDR--LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFL--HDKG 144
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
+I+RDL NV ++ + G K+ D
Sbjct: 145 IIYRDLKLDNVLLD-HEGHCKLADF 168
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 43.9 bits (102), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG GA V R + G+E A + + ++L E R+ + L + NI+
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH ++E + L F ++ T G L E S +QIL+ + Y H++
Sbjct: 70 LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 125
Query: 151 VIHRDLNCSNVFVNGNT--GQVKIGDL 175
++HR+L N+ + VK+ D
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADF 152
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 43.5 bits (101), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG GA V R + G+E A + + ++L E R+ + L + NI+
Sbjct: 11 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 68
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH ++E + L F ++ T G L E S +QIL+ + Y H++
Sbjct: 69 LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 124
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
++HR+L N+ + VK+ D
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADF 151
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 43.5 bits (101), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
T Y + EL G GA V R G E A + + D +ER E R+ +
Sbjct: 3 TDEYQLFEEL-GKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+ LH +E + L F ++ T G L E + S +QIL+ +
Sbjct: 59 LLKHPNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
N H H ++HRDL N+ + + VK+ D
Sbjct: 117 N--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
T Y + EL G GA V R G E A + + D +ER E R+ +
Sbjct: 3 TDEYQLFEEL-GKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+ LH +E + L F ++ T G L E + S +QIL+ +
Sbjct: 59 LLKHPNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILESV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
N H H ++HRDL N+ + + VK+ D
Sbjct: 117 N--HCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 64/147 (43%), Gaps = 8/147 (5%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG GA V R + G+E A + + ++L E R+ + L + NI+
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL--SARDFQKLEREARICRKLQHPNIVR 69
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
LH ++E + L F ++ T G L E S +QIL+ + Y H++
Sbjct: 70 LHDSIQEESFHYLVF--DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN--G 125
Query: 151 VIHRDLNCSNVFV--NGNTGQVKIGDL 175
++HR+L N+ + VK+ D
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADF 152
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ +V A + I A ++ + F +D ++R E+ ++K+L + NII L+
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIRLY 72
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCV 151
+ ED + + E+CT G L E R H+ V ++ + K +L + Y H V
Sbjct: 73 ETF--EDNTDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN--V 127
Query: 152 IHRDLNCSNVF 162
HRDL N
Sbjct: 128 AHRDLKPENFL 138
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 43.5 bits (101), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 37/131 (28%), Positives = 63/131 (48%), Gaps = 10/131 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ +V A + I A ++ + F +D ++R E+ ++K+L + NII L+
Sbjct: 34 IGRGSWGEVKIAVQKGTRIRRAAKKIP-KYFVED---VDRFKQEIEIMKSLDHPNIIRLY 89
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKA-LKKWSKQILKGLNYLHTHEPCV 151
+ ED + + E+CT G L E R H+ V ++ + K +L + Y H V
Sbjct: 90 ETF--EDNTDIYLVMELCTGGELFE-RVVHKRVFRESDAARIMKDVLSAVAYCHKLN--V 144
Query: 152 IHRDLNCSNVF 162
HRDL N
Sbjct: 145 AHRDLKPENFL 155
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 9/147 (6%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
L+G G+ VY A+D+ VA +V R F +D +R+ E+ +L L + II L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKVN-RMF-EDLIDCKRILREITILNRLKSDYIIRL 90
Query: 92 HYVWRDEDR---NTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
+ + +D + L + E+ S +L++ K ++ + +K +L G N++H E
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH--E 147
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N +N + VK+ D
Sbjct: 148 SGIIHRDLKPANCLLNQDCS-VKVCDF 173
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+++G+G+ VY+A + G VA +V A R E+++++ L + NI+
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90 SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
L Y + +D LN + + + R Y + + + V +K + Q+ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 43.5 bits (101), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 101 NTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS 159
++L +T+ G+L ++ ++HR + + L W QI KG+ YL H ++HR+L
Sbjct: 105 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 162
Query: 160 NVFVNGNTGQVKIGDL 175
NV + + QV++ D
Sbjct: 163 NVLLK-SPSQVQVADF 177
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 23/76 (30%), Positives = 42/76 (55%), Gaps = 4/76 (5%)
Query: 101 NTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS 159
++L +T+ G+L ++ ++HR + + L W QI KG+ YL H ++HR+L
Sbjct: 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH--GMVHRNLAAR 144
Query: 160 NVFVNGNTGQVKIGDL 175
NV + + QV++ D
Sbjct: 145 NVLLK-SPSQVQVADF 159
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY A +++ +A +V +T + + +L EV + L + NI+ L+
Sbjct: 20 LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ D R L I E G + +K + + ++ L+Y H+ VI
Sbjct: 79 GYFHDATRVYL--ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ N+ + G+ G++KI D
Sbjct: 135 HRDIKPENLLL-GSNGELKIADF 156
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 43.1 bits (100), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 29 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 78
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 79 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 138
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 139 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 171
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 26 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 75
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 76 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 135
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 136 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 168
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 37/143 (25%), Positives = 65/143 (45%), Gaps = 6/143 (4%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G VY A +++ +A +V +T + + +L EV + L + NI+ L+
Sbjct: 20 LGKGKFGNVYLARERQSKFILAL-KVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLY 78
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVI 152
+ D R L I E G + +K + + ++ L+Y H+ VI
Sbjct: 79 GYFHDATRVYL--ILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR--VI 134
Query: 153 HRDLNCSNVFVNGNTGQVKIGDL 175
HRD+ N+ + G+ G++KI D
Sbjct: 135 HRDIKPENLLL-GSNGELKIADF 156
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 43/157 (27%), Positives = 75/157 (47%), Gaps = 22/157 (14%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG GA +V +A + + A +++ + + SEV LL +L ++ ++
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 92 HYVWRDEDRNTLNFITEVCTSGNL---REY---RKKHRHVSVKALKK-----WS--KQIL 138
+ W E RN + +T V L EY R + + + L + W +QIL
Sbjct: 68 YAAWL-ERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L+Y+H+ +IHRDL N+F++ + VKIGD
Sbjct: 127 EALSYIHSQ--GIIHRDLKPMNIFID-ESRNVKIGDF 160
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 26/164 (15%)
Query: 33 LGSGAVKKVYRA----FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKN 87
LG GA +V A D+++ V VK+ + L SE+ ++K + +KN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRK----------------KHRHVSVKALK 131
II+L + L I E + GNLREY + +S K L
Sbjct: 96 IINLLGACTQD--GPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLV 153
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+ +G+ YL + + IHRDL NV V + +KI D
Sbjct: 154 SCAYQVARGMEYLASKK--CIHRDLAARNVLVTEDN-VMKIADF 194
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 44 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 93
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 94 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 153
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 154 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 186
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 37 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 86
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 87 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 147 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 179
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
Y + +G G V++ ++ VA + L + MIE+ EV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
+ NI+ L+ + + R + F+ G+L HR + KWS + I
Sbjct: 82 HPNIVKLYGLMHNPPRMVMEFVP----CGDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
G+ Y+ P ++HRDL N+F+
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 38 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 87
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 88 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 147
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 148 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 180
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
+GSG+ VY+ W+ VK L P ++ +EV +L+ + NI
Sbjct: 32 IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
+ + L +T+ C +L H H S +K L ++Q +G++Y
Sbjct: 83 LLFMGY---STKPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 135
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
LH +IHRDL +N+F++ + VKIGD
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 164
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 33 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 82
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 83 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 142
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 143 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 175
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 42.7 bits (99), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 36/146 (24%), Positives = 63/146 (43%), Gaps = 18/146 (12%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
Y + +G G V++ ++ VA + L + MIE+ EV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
+ NI+ L+ + + R + F+ C G+L HR + KWS + I
Sbjct: 82 HPNIVKLYGLMHNPPRMVMEFVP--C--GDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
G+ Y+ P ++HRDL N+F+
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/146 (23%), Positives = 62/146 (42%), Gaps = 18/146 (12%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS---EVRLLKTLA 84
Y + +G G V++ ++ VA + L + MIE+ EV ++ L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 85 NKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQ------IL 138
+ NI+ L+ + + R + F+ G+L HR + KWS + I
Sbjct: 82 HPNIVKLYGLMHNPPRMVMEFVP----CGDLY-----HRLLDKAHPIKWSVKLRLMLDIA 132
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVN 164
G+ Y+ P ++HRDL N+F+
Sbjct: 133 LGIEYMQNQNPPIVHRDLRSPNIFLQ 158
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
+GSG+ VY+ W+ VK L P ++ +EV +L+ + NI
Sbjct: 20 IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 70
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
+ + L +T+ C +L H H S +K L ++Q +G++Y
Sbjct: 71 LLFMGY---STKPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 123
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
LH +IHRDL +N+F++ + VKIGD
Sbjct: 124 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 152
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 37 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 86
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 87 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 146
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 147 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 179
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+++G+G+ VY+A + G VA +V A R E+++++ L + NI+
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90 SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
L Y + +D LN + + R Y + + + V +K + Q+ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 30 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 79
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 80 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 139
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 140 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 172
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 16/164 (9%)
Query: 18 IETDPTGRYGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIER--L 73
+E Y Y+ E LGSGA V+R +E A +V + F + P +++ +
Sbjct: 42 VEVKQGSVYDYYDILEELGSGAFGVVHRC------VEKATGRVFVAKFINTPYPLDKYTV 95
Query: 74 FSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSVKALKK 132
+E+ ++ L + +I+LH + ED+ + I E + G L + + +S +
Sbjct: 96 KNEISIMNQLHHPKLINLHDAF--EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 133 WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGDL 175
+ +Q +GL ++H H ++H D+ N+ VKI D
Sbjct: 154 YMRQACEGLKHMHEH--SIVHLDIKPENIMCETKKASSVKIIDF 195
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 53 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 102
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 103 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 162
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 163 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 195
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 42.7 bits (99), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 71/153 (46%), Gaps = 17/153 (11%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+++G+G+ VY+A + G VA +V A R E+++++ L + NI+
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQGKAFKNR---ELQIMRKLDHCNIV 76
Query: 90 SLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKGLN 142
L Y + +D LN + + R Y + + + V +K + Q+ + L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 137 YIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 108
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 169 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 201
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 61 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 110
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 111 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 170
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 171 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 203
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 104 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 153
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 154 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 213
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 214 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 246
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 63 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 112
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 113 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 172
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 173 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 205
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 59 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 108
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 168
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 169 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 201
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL 83
R ++LGSGA VY+ +G I VA ++ T P + + E ++ +
Sbjct: 20 RKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT---SPKANKEILDEAYVMAGV 76
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALKKWSKQILKGLN 142
+ + L + +T+ +T++ G L ++ +++R + + L W QI KG++
Sbjct: 77 GSPYVSRLLGICL---TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
YL ++HRDL NV V + VKI D
Sbjct: 134 YLEDVR--LVHRDLAARNVLVK-SPNHVKITDF 163
>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC
Length = 405
Score = 42.4 bits (98), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 36/111 (32%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 76 EVRLLKTLANKNIISLHYVWRDE-DRNT-LNF------ITEVCTSGNLREYRKKHRHVSV 127
E+ LL+ L + N+ISL V+ DR L F + + + KK +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT---GQVKIGDL 175
+K QIL G++YLH + V+HRDL +N+ V G G+VKI D+
Sbjct: 128 GMVKSLLYQILDGIHYLHAN--WVLHRDLKPANILVMGEGPERGRVKIADM 176
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 42.0 bits (97), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 35/155 (22%), Positives = 73/155 (47%), Gaps = 21/155 (13%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS--EVRLLKTLANKN 87
+++G+G+ VY+A + G VA +V + ++ F E+++++ L + N
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGELVAIKKV----------LQDKRFKNRELQIMRKLDHCN 74
Query: 88 IISLHYVW----RDEDRNTLNFITEVCTSGNLR---EYRKKHRHVSVKALKKWSKQILKG 140
I+ L Y + +D LN + + R Y + + + V +K + Q+ +
Sbjct: 75 IVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 141 LNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L Y+H+ C HRD+ N+ ++ +T +K+ D
Sbjct: 135 LAYIHSFGIC--HRDIKPQNLLLDPDTAVLKLCDF 167
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 19 ERLGAGQAGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 73 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 30/121 (24%), Positives = 56/121 (46%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + E E ++ L++ ++ L+ V ++ + +TE G L
Sbjct: 33 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--APICLVTEFMEHGCL 90
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E CVIHRDL N V G +K+ D
Sbjct: 91 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 147
Query: 175 L 175
Sbjct: 148 F 148
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
T Y Y ++ G GA V R G E A + + D +ER E R+ +
Sbjct: 3 TDEYQLYEDI-GKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICR 58
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+ LH +E + L F ++ T G L E + S +QIL+ +
Sbjct: 59 LLKHSNIVRLHDSISEEGFHYLVF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV 116
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
LH H+ V+HRDL N+ + VK+ D
Sbjct: 117 --LHCHQMGVVHRDLKPENLLLASKCKGAAVKLADF 150
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 42.0 bits (97), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 14 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDA-----FLAEANLMKQLQHQRLVR 67
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 68 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 122
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 123 RNYIHRDLRAANILVS-DTLSCKIADF 148
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 28 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 81
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 82 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 136
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 137 RNYIHRDLRAANILVS-DTLSCKIADF 162
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 29 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 82
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 83 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 137
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 138 RNYIHRDLRAANILVS-DTLSCKIADF 163
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 72
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 73 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 27 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 80
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 81 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 135
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 136 RNYIHRDLRAANILVS-DTLSCKIADF 161
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 25 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 78
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 79 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 133
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 134 RNYIHRDLRAANILVS-DTLSCKIADF 159
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 44/156 (28%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 23 TGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTF-CDDPAMIERLFSEVRLLK 81
T Y + EL G GA V R G E A + + D +ER E R+ +
Sbjct: 10 TEEYQLFEEL-GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICR 65
Query: 82 TLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
L + NI+ LH +E + L F ++ T G L E + S +QIL+ +
Sbjct: 66 LLKHPNIVRLHDSISEEGHHYLIF--DLVTGGELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNT--GQVKIGDL 175
LH H+ V+HR+L N+ + VK+ D
Sbjct: 124 --LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/147 (27%), Positives = 67/147 (45%), Gaps = 11/147 (7%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG G+ KV A + +VA + R M R+ E+ LK L + +II
Sbjct: 15 ETLGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 91 LHYVWRDEDRNTLNFITEVC--TSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
L+ V T I V G L +Y + + ++ +++ +QI+ + Y H H+
Sbjct: 74 LYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRDL N+ ++ N VKI D
Sbjct: 129 --IVHRDLKPENLLLDDNLN-VKIADF 152
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 21 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 74
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 75 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 129
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 130 RNYIHRDLRAANILVS-DTLSCKIADF 155
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 25 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 78
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 79 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 133
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 134 RNYIHRDLRAANILVS-DTLSCKIADF 159
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 41.6 bits (96), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 28/152 (18%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWN---QVK-LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
+GSG+ VY+ W+ VK L P ++ +EV +L+ + NI
Sbjct: 32 IGSGSFGTVYKG---------KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNI 82
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVS-----VKALKKWSKQILKGLNY 143
+ L +T+ C +L H H S +K L ++Q +G++Y
Sbjct: 83 LLFMGY---STAPQLAIVTQWCEGSSLYH----HLHASETKFEMKKLIDIARQTARGMDY 135
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
LH +IHRDL +N+F++ + VKIGD
Sbjct: 136 LHAK--SIIHRDLKSNNIFLHEDN-TVKIGDF 164
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +V +++ + +E L+K L ++ ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 73 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 38/147 (25%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +VA +K + D +E L+K L ++ ++
Sbjct: 24 ERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPD-----AFLAEANLMKQLQHQRLVR 77
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 78 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 132
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 133 RNYIHRDLRAANILVS-DTLSCKIADF 158
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 41.6 bits (96), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +V +++ + +E L+K L ++ ++
Sbjct: 19 ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 73 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 127
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 128 RNYIHRDLRAANILVS-DTLSCKIADF 153
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 41.2 bits (95), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 14/147 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
E LG+G +V+ + +V +++ + +E L+K L ++ ++
Sbjct: 20 ERLGAGQFGEVWMGYYNGH------TKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 91 LHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV--SVKALKKWSKQILKGLNYLHTHE 148
L+ V E + ITE +G+L ++ K + ++ L + QI +G+ ++ E
Sbjct: 74 LYAVVTQE---PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--E 128
Query: 149 PCVIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL +N+ V+ +T KI D
Sbjct: 129 RNYIHRDLRAANILVS-DTLSCKIADF 154
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
PF D +Y + ++ G G +V++A ++ G +VA +V + +
Sbjct: 11 PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 65
Query: 76 EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
E+++L+ L ++N+++L + R + + ++ + + C +G L K +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 122
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +K+ + +L GL Y+H ++ ++HRD+ +NV + + G +K+ D
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 168
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 41.2 bits (95), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKXVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 40.8 bits (94), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 34/160 (21%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 27 GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
+Y +L +G G +V++A ++ G +VA +V + + E+++L+ L
Sbjct: 18 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKILQLLK 75
Query: 85 NKNIISLHYVWRDED------RNTLNFITEVCT---SGNLREYRKKHRHVSVKALKKWSK 135
++N+++L + R + + ++ + + C +G L K ++ +K+ +
Sbjct: 76 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQ 132
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+L GL Y+H ++ ++HRD+ +NV + + G +K+ D
Sbjct: 133 MLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 40.8 bits (94), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
PF D +Y + ++ G G +V++A ++ G +VA +V + +
Sbjct: 12 PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 66
Query: 76 EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
E+++L+ L ++N+++L + R + + ++ + + C +G L K +
Sbjct: 67 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +K+ + +L GL Y+H ++ ++HRD+ +NV + + G +K+ D
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKCVNH 75
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSDXT-LKILDF 163
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + E E ++ L++ ++ L+ V ++ L F E G L
Sbjct: 30 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 87
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E CVIHRDL N V G +K+ D
Sbjct: 88 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 144
Query: 175 L 175
Sbjct: 145 F 145
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLXGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDXT-LKILDF 170
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 36/169 (21%), Positives = 83/169 (49%), Gaps = 20/169 (11%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFS 75
PF D +Y + ++ G G +V++A ++ G +VA +V + +
Sbjct: 12 PF--CDEVSKYEKLAKI-GQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALR 66
Query: 76 EVRLLKTLANKNIISLHYVWRDED------RNTLNFITEVC---TSGNLREYRKKHRHVS 126
E+++L+ L ++N+++L + R + + ++ + + C +G L K +
Sbjct: 67 EIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVK---FT 123
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +K+ + +L GL Y+H ++ ++HRD+ +NV + + G +K+ D
Sbjct: 124 LSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRD-GVLKLADF 169
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + E E ++ L++ ++ L+ V ++ L F E G L
Sbjct: 32 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 89
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E CVIHRDL N V G +K+ D
Sbjct: 90 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 146
Query: 175 L 175
Sbjct: 147 F 147
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 40.4 bits (93), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 40/166 (24%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG GA +V +A + + A +++ + + SEV LL +L ++ ++
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIR-----HTEEKLSTILSEVXLLASLNHQYVVRY 67
Query: 92 HYVWRD-----------EDRNTLNFITEVCT---------SGNLREYRKKHRHVSVKALK 131
+ W + + ++TL E C S NL + R ++
Sbjct: 68 YAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEY--------- 118
Query: 132 KWS--KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
W +QIL+ L+Y+H+ +IHR+L N+F++ + VKIGD
Sbjct: 119 -WRLFRQILEALSYIHSQ--GIIHRNLKPXNIFID-ESRNVKIGDF 160
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 40.4 bits (93), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + E E ++ L++ ++ L+ V ++ L F E G L
Sbjct: 35 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 92
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E CVIHRDL N V G +K+ D
Sbjct: 93 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 149
Query: 175 L 175
Sbjct: 150 F 150
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 40.4 bits (93), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 33/145 (22%), Positives = 62/145 (42%), Gaps = 9/145 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ K E+G + ++ + R EV +L + + NI+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESR--REVAVLANMKHPNIV--Q 87
Query: 93 YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK--ALKKWSKQILKGLNYLHTHEPC 150
Y E+ +L + + C G+L + + V + + W QI L H H+
Sbjct: 88 YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALK--HVHDRK 145
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
++HRD+ N+F+ + G V++GD
Sbjct: 146 ILHRDIKSQNIFLTKD-GTVQLGDF 169
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 40.4 bits (93), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 38 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 96
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 97 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 154
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 155 --GIIHRDLKPENILLNEDM-HIQITDF 179
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 40.0 bits (92), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 40.0 bits (92), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 36 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 94
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 95 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 153 --GIIHRDLKPENILLNEDM-HIQITDF 177
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 36 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 94
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 95 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 152
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 153 --GIIHRDLKPENILLNEDM-HIQITDF 177
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 13 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 71
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 72 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 129
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 130 --GIIHRDLKPENILLNEDM-HIQITDF 154
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 92 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDF 174
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
AM+E+ ++L + ++ I+SL Y + E + L + + G++R Y +
Sbjct: 232 AMVEK-----KILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 126 SVKALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + ++ QI+ GL +LH +I+RDL NV ++ + G V+I DL
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDL 333
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 92 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDF 174
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 33 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 92 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDF 174
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 12 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 70
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 71 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 128
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 129 --GIIHRDLKPENILLNEDM-HIQITDF 153
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
AM+E+ ++L + ++ I+SL Y + E + L + + G++R Y +
Sbjct: 232 AMVEK-----KILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 126 SVKALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + ++ QI+ GL +LH +I+RDL NV ++ + G V+I DL
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDL 333
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
AM+E+ ++L + ++ I+SL Y + E + L + + G++R Y +
Sbjct: 232 AMVEK-----KILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 126 SVKALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + ++ QI+ GL +LH +I+RDL NV ++ + G V+I DL
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDL 333
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 30/112 (26%), Positives = 57/112 (50%), Gaps = 14/112 (12%)
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLRE--YRKKHRHV 125
AM+E+ ++L + ++ I+SL Y + E + L + + G++R Y +
Sbjct: 232 AMVEK-----KILAKVHSRFIVSLAYAF--ETKTDLCLVMTIMNGGDIRYHIYNVDEDNP 284
Query: 126 SVKALKK--WSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ + ++ QI+ GL +LH +I+RDL NV ++ + G V+I DL
Sbjct: 285 GFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLD-DDGNVRISDL 333
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 10 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 68
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 69 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 126
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 127 --GIIHRDLKPENILLNEDM-HIQITDF 151
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 40.0 bits (92), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/152 (25%), Positives = 60/152 (39%), Gaps = 13/152 (8%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+ G G V ++ G+ VA +V DP R ++ L L + NI+ L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 92 H---YVWRDEDRNT--LNFITEVCTSG---NLREYRKKHRHVSVKALKKWSKQILKGLNY 143
Y + DR LN + E R Y ++ +K + Q+++ +
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144
Query: 144 LHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
LH V HRD+ NV VN G +K+ D
Sbjct: 145 LHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 69
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 70 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 128 --GIIHRDLKPENILLNEDM-HIQITDF 152
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 40 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 98
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 99 FVKLYFCFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 156
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 157 --GIIHRDLKPENILLNEDM-HIQITDF 181
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 44/153 (28%), Positives = 74/153 (48%), Gaps = 26/153 (16%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA-NKNIISL 91
LG GA V+++ D+ G VA K+ + +R F E+ +L L+ ++NI++L
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVK--KIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 92 HYVWR-DEDRNT-LNFITEVCTSGNLREYRKKHRHVSVKA--LKKWSKQ-----ILKGLN 142
V R D DR+ L F +Y + H ++A L+ KQ ++K +
Sbjct: 75 LNVLRADNDRDVYLVF-----------DYMETDLHAVIRANILEPVHKQYVVYQLIKVIK 123
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
YLH+ ++HRD+ SN+ +N VK+ D
Sbjct: 124 YLHSG--GLLHRDMKPSNILLNAEC-HVKVADF 153
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/153 (20%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIIS 90
+++G+G+ V++A E ++V ++ D R E+++++ + + N++
Sbjct: 46 KVIGNGSFGVVFQAKLVES------DEVAIKKVLQDKRFKNR---ELQIMRIVKHPNVVD 96
Query: 91 LH-YVWRDEDRN-------TLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLN 142
L + + + D+ L ++ E + R Y K + + + +K + Q+L+ L
Sbjct: 97 LKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS-RHYAKLKQTMPMLLIKLYMYQLLRSLA 155
Query: 143 YLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Y+H+ C HRD+ N+ ++ +G +K+ D
Sbjct: 156 YIHSIGIC--HRDIKPQNLLLDPPSGVLKLIDF 186
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKXVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDX-TLKILDF 170
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 120
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 178 KHLHSAG--IIHRDLKPSNIVVKSD 200
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 17 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 75
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 76 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 133
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 134 --GIIHRDLKPENILLNEDM-HIQITDF 158
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 5/146 (3%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+++LG G+ KV+ A ++ A +K D +E E R+L +LA ++
Sbjct: 22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-VECTMVEKRVL-SLAWEHPF 79
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
H + + L F+ E G+L + + + ++ +I+ GL +LH+
Sbjct: 80 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-- 137
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++RDL N+ ++ + G +KI D
Sbjct: 138 GIVYRDLKLDNILLDKD-GHIKIADF 162
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 33/134 (24%), Positives = 63/134 (47%), Gaps = 8/134 (5%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
+ E+LGSGA +V+ + G A +K D + L +E+ +LK + ++NI
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS----LENEIAVLKKIKHENI 68
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHE 148
++L ++ E + ++ + G L + + + K +Q+L + YLH E
Sbjct: 69 VTLEDIY--ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH--E 124
Query: 149 PCVIHRDLNCSNVF 162
++HRDL N+
Sbjct: 125 NGIVHRDLKPENLL 138
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 39.7 bits (91), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 32 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 90
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 91 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 149 --GIIHRDLKPENILLNEDM-HIQITDF 173
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 39.3 bits (90), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 32 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 90
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 91 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 148
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 149 --GIIHRDLKPENILLNEDM-HIQITDF 173
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 5/146 (3%)
Query: 30 NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNII 89
+++LG G+ KV+ A ++ A +K D +E E R+L +LA ++
Sbjct: 23 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDD-VECTMVEKRVL-SLAWEHPF 80
Query: 90 SLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
H + + L F+ E G+L + + + ++ +I+ GL +LH+
Sbjct: 81 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK-- 138
Query: 150 CVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++RDL N+ ++ + G +KI D
Sbjct: 139 GIVYRDLKLDNILLDKD-GHIKIADF 163
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/149 (22%), Positives = 70/149 (46%), Gaps = 9/149 (6%)
Query: 31 ELLGSGAVKKVY---RAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL-ANK 86
++LG+GA KV+ + + G A +K T E +E ++L+ + +
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
+++LHY ++ E + L+ I + G L + + + ++ + +I+ L H
Sbjct: 120 FLVTLHYAFQTETK--LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE--HL 175
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
H+ +I+RD+ N+ ++ N G V + D
Sbjct: 176 HKLGIIYRDIKLENILLDSN-GHVVLTDF 203
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 120
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 177
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 178 KHLHS--AGIIHRDLKPSNIVVKSD 200
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 33/157 (21%), Positives = 73/157 (46%), Gaps = 12/157 (7%)
Query: 26 YGRYN--ELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR----- 78
Y +Y+ +++G G V R + G E A +++ P +E + R
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
L + + +II+L + E + + + ++ G L +Y + +S K + + +L
Sbjct: 153 LRQVAGHPHIITLIDSY--ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ +++LH + ++HRDL N+ ++ N Q+++ D
Sbjct: 211 EAVSFLHANN--IVHRDLKPENILLDDNM-QIRLSDF 244
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 30/121 (24%), Positives = 55/121 (45%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + + E ++ L++ ++ L+ V ++ L F E G L
Sbjct: 52 DKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 109
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E CVIHRDL N V G +K+ D
Sbjct: 110 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EACVIHRDLAARNCLV-GENQVIKVSD 166
Query: 175 L 175
Sbjct: 167 F 167
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 83
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 84 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSD 163
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 83
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 84 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSD 163
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 24 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 81
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 82 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 138
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 139 KHLHS--AGIIHRDLKPSNIVVKSD 161
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLS-RPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDF 170
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 77 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSD 156
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 77 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSD 156
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 39.3 bits (90), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/145 (28%), Positives = 70/145 (48%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 75
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 132
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 133 KHLHS--AGIIHRDLKPSNIVVKSD 155
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 74/154 (48%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPF-QNQTHAKRAYRELVLMKXVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNIISL V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSDX-TLKILDF 170
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 75 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 128 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 153
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 74
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 75 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 127
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 128 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 153
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 98 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 151 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 176
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 70 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 123 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 148
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 70 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 123 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 148
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 18 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 71
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 72 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 124
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 125 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 150
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 43 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 96
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 97 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 149
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 150 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 175
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 19/41 (46%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K+ILKGL+YLH+ + IHRD+ +NV ++ G VK+ D
Sbjct: 127 KEILKGLDYLHSEKK--IHRDIKAANVLLS-EQGDVKLADF 164
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 42/159 (26%), Positives = 69/159 (43%), Gaps = 43/159 (27%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDR--------------N 101
N+ K+R +P +ER+ +EVRL+K L + NI L+ V+ DE +
Sbjct: 60 NKNKIRQI--NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117
Query: 102 TLN-FI-------------TEVC---------TSGNLREYRKKHRHVS-VKALKKWSKQI 137
LN FI T++C +G++ +R+ V K + +QI
Sbjct: 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI 177
Query: 138 LKGLNYLHTHEPCVIHRDLNCSN-VFVNGNTGQVKIGDL 175
L+YLH C HRD+ N +F + ++K+ D
Sbjct: 178 FSALHYLHNQGIC--HRDIKPENFLFSTNKSFEIKLVDF 214
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 97
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 98 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 150
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 151 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 176
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 32/148 (21%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ V A + E A ++ R + + + E ++ L +
Sbjct: 35 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 93
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 94 FVKLYFTFQDDEK--LYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 151
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 152 --GIIHRDLKPENILLNEDM-HIQITDF 176
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 36/149 (24%), Positives = 68/149 (45%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+
Sbjct: 36 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 89
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 90 MGY---STKPQLAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 142
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 143 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 168
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 38.9 bits (89), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 52/188 (27%), Positives = 78/188 (41%), Gaps = 38/188 (20%)
Query: 2 MPAVNSDPS-DKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKL 60
M A S+PS D D+ +E GRYG VY+ E + VK+
Sbjct: 1 MEAAASEPSLDLDNLKLLELIGRGRYG------------AVYKGSLDERPV-----AVKV 43
Query: 61 RTFCDDPAMI-ERLFSEVRLLKTLANKNIISLHYVWRDE-----DRNTLNFITEVCTSGN 114
+F + I E+ V L++ + NI ++ DE R + E +G+
Sbjct: 44 FSFANRQNFINEKNIYRVPLME---HDNIA--RFIVGDERVTADGRMEYLLVMEYYPNGS 98
Query: 115 LREYRKKHRHVSVKALKKWSKQILKGLNYLHT-------HEPCVIHRDLNCSNVFVNGNT 167
L +Y H V + + + + +GL YLHT ++P + HRDLN NV V N
Sbjct: 99 LXKYLSLHTSDWVSSCR-LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVK-ND 156
Query: 168 GQVKIGDL 175
G I D
Sbjct: 157 GTCVISDF 164
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 28/94 (29%), Positives = 47/94 (50%), Gaps = 6/94 (6%)
Query: 84 ANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNY 143
+ NI+ LH V+ D+ L + E+ G L E KK +H S ++++ ++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFL--VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS- 120
Query: 144 LHTHEPCVIHRDLNCSN-VFVNGNTG-QVKIGDL 175
H H+ V+HRDL N +F + N ++KI D
Sbjct: 121 -HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDF 153
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 32/136 (23%), Positives = 63/136 (46%), Gaps = 9/136 (6%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDD----PAMIERLFSEVRLLKTLANKNI 88
LGSGA V+ A D+E+ EV +K +D + ++ E+ +L + + NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSG-NLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I + ++ E++ + E SG +L + +H + +Q++ + YL
Sbjct: 92 IKVLDIF--ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK 149
Query: 148 EPCVIHRDLNCSNVFV 163
+ +IHRD+ N+ +
Sbjct: 150 D--IIHRDIKDENIVI 163
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 67 PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV 125
P + + E R+LK ++ NI+ L V + + + E+ G+ + R + +
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
VK L + G+ YL + C IHRDL N V +KI D
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVT-EKNVLKISDF 257
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 29/110 (26%), Positives = 47/110 (42%), Gaps = 6/110 (5%)
Query: 67 PAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHV 125
P + + E R+LK ++ NI+ L V + + + E+ G+ + R + +
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVC--TQKQPIYIVMELVQGGDFLTFLRTEGARL 210
Query: 126 SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
VK L + G+ YL + C IHRDL N V +KI D
Sbjct: 211 RVKTLLQMVGDAAAGMEYLESK--CCIHRDLAARNCLVT-EKNVLKISDF 257
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/173 (24%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 6 NSDPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCD 65
+S P+ P + RY L+G+G+ V A+D+ E VA ++ LR F +
Sbjct: 35 SSKPTASMPRPHSDWQIPDRY-EIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVF-E 91
Query: 66 DPAMIERLFSEVRLLKTLANKNIISLH--YVWRD-EDRNTLNFITEVCTSGNLREYRKKH 122
D +R+ E+ +L L + +++ + + +D E + L + E+ S + +R
Sbjct: 92 DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP- 150
Query: 123 RHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++ +K +L G+ Y+H+ ++HRDL +N VN + VK+ D
Sbjct: 151 VYLTELHIKTLLYNLLVGVKYVHS--AGILHRDLKPANCLVNQDCS-VKVCDF 200
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 33/149 (22%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 31 ELLGSGAVKKVYRAFDQEE----GIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANK 86
+++G G+ KV A + E ++V + L+ + M ER LLK + +
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSER----NVLLKNVKHP 99
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
++ LH+ ++ D+ L F+ + G L + ++ R + ++ +I L YLH+
Sbjct: 100 FLVGLHFSFQTADK--LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS 157
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+++RDL N+ ++ + G + + D
Sbjct: 158 LN--IVYRDLKPENILLD-SQGHIVLTDF 183
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 31/148 (20%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKN 87
++ ++LG G+ A + E A ++ R + + + E ++ L +
Sbjct: 33 KFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKE-NKVPYVTRERDVMSRLDHPF 91
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+ L++ ++D+++ L F +G L +Y +K + ++ +I+ L YLH
Sbjct: 92 FVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 149
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL N+ +N + ++I D
Sbjct: 150 --GIIHRDLKPENILLNEDM-HIQITDF 174
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ILKGL+YLH+ + IHRD+ +NV ++ + G+VK+ D
Sbjct: 111 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADF 148
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 38.5 bits (88), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ILKGL+YLH+ + IHRD+ +NV ++ + G+VK+ D
Sbjct: 111 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADF 148
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 38.1 bits (87), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ILKGL+YLH+ + IHRD+ +NV ++ + G+VK+ D
Sbjct: 126 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADF 163
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ILKGL+YLH+ + IHRD+ +NV ++ + G+VK+ D
Sbjct: 131 REILKGLDYLHSEKK--IHRDIKAANVLLSEH-GEVKLADF 168
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDF 170
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 71/161 (44%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 2 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + + +L ++ + + + + +
Sbjct: 62 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF 120
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 121 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLVGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDF 170
>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With
Bound Adp
pdb|1Q8Y|B Chain B, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With
Bound Adp
pdb|1Q8Z|A Chain A, The Apoenzyme Structure Of The Yeast Sr Protein Kinase,
Sky1p
pdb|1Q8Z|B Chain B, The Apoenzyme Structure Of The Yeast Sr Protein Kinase,
Sky1p
pdb|1Q97|A Chain A, The Structure Of The Saccharomyces Cerevisiae Sr Protein
Kinase, Sky1p, With Bound Atp
pdb|1Q97|B Chain B, The Structure Of The Saccharomyces Cerevisiae Sr Protein
Kinase, Sky1p, With Bound Atp
pdb|1Q99|A Chain A, Crystal Structure Of The Saccharomyces Cerevisiae Sr
Protein Kinsae, Sky1p, Complexed With The
Non-Hydrolyzable Atp Analogue, Amp-Pnp
pdb|1Q99|B Chain B, Crystal Structure Of The Saccharomyces Cerevisiae Sr
Protein Kinsae, Sky1p, Complexed With The
Non-Hydrolyzable Atp Analogue, Amp-Pnp
Length = 373
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK----------- 81
LG G V+ A D VA V+ D E E++LL+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 82 TLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQIL 138
++ +I+ L H+ + + + + EV L +K +HR + + +K+ SKQ+L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 139 KGLNYLHTHEPC-VIHRDLNCSNVFVN-----GNTGQVKIGDL 175
GL+Y+H C +IH D+ NV + N Q+KI DL
Sbjct: 142 LGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase
In Yeast
pdb|2JD5|A Chain A, Sky1p Bound To Npl3p-Derived Substrate Peptide
pdb|2JD5|B Chain B, Sky1p Bound To Npl3p-Derived Substrate Peptide
Length = 373
Score = 38.1 bits (87), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLK----------- 81
LG G V+ A D VA V+ D E E++LL+
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVR-----GDKVYTEAAEDEIKLLQRVNDADNTKED 81
Query: 82 TLANKNIISL--HYVWRDEDRNTLNFITEVCTSGNLREYRK-KHRHVSVKALKKWSKQIL 138
++ +I+ L H+ + + + + EV L +K +HR + + +K+ SKQ+L
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 139 KGLNYLHTHEPC-VIHRDLNCSNVFVN-----GNTGQVKIGDL 175
GL+Y+H C +IH D+ NV + N Q+KI DL
Sbjct: 142 LGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADL 182
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 14 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 74 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 132
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 133 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 28 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 88 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 147 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 27 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 87 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 146 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 27 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 87 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 146 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 28 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 88 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 147 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 15 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 75 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 134 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 14 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 74 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 132
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 133 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 22/149 (14%)
Query: 33 LGSGAVKKVYRA-FDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+GSG+ VY+ + + +++ L P ++ +EV +L+ + NI+ L
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKM------LNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-L 68
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHV-----SVKALKKWSKQILKGLNYLHT 146
+ + L +T+ C +L H H+ + L ++Q +G++YLH
Sbjct: 69 FMGYSTAPQ--LAIVTQWCEGSSLYH----HLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+IHRDL +N+F++ + VKIGD
Sbjct: 123 K--SIIHRDLKSNNIFLHEDL-TVKIGDF 148
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 28 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 88 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 147 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 27 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 87 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 146 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 15 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 75 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 134 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 27 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 87 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 145
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 146 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 28 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 88 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 146
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 147 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 15 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 75 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 133
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 134 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 42 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 102 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 161 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 94 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 153 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 37.7 bits (86), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 47 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 107 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 165
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 166 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 37.4 bits (85), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 37/164 (22%), Positives = 71/164 (43%), Gaps = 7/164 (4%)
Query: 16 PFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RL 73
P E +P + LLGSG VY + + VA V+ D + R+
Sbjct: 42 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 74 FSEVRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK 131
EV LLK +++ +I L W + + + + +L ++ + + + +
Sbjct: 102 PMEVVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 160
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 161 SFFWQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 37.4 bits (85), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 18/41 (43%), Positives = 27/41 (65%), Gaps = 3/41 (7%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ILKGL+YLH+ IHRD+ +NV ++ G VK+ D
Sbjct: 123 REILKGLDYLHSERK--IHRDIKAANVLLS-EQGDVKLADF 160
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQ-THAKRAYRELVLMKVVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDF 170
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFS-EVRLLKTLA 84
++ +++G G +V +A +++G+ + A ++K DD R F+ E+ +L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLG 83
Query: 85 N-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSV 127
+ NII+L + E R L E GNL ++ +K R +S
Sbjct: 84 HHPNIINL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L ++ + +G++YL + IHRDL N+ V G KI D
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADF 186
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 37.4 bits (85), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 43/168 (25%), Positives = 76/168 (45%), Gaps = 29/168 (17%)
Query: 28 RYNELLGSGAVKKVYRAFDQEEGI--EVAWNQVKLRTFCDDPAMIERLFS-EVRLLKTLA 84
++ +++G G +V +A +++G+ + A ++K DD R F+ E+ +L L
Sbjct: 18 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLG 73
Query: 85 N-KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR----------------HVSV 127
+ NII+L + E R L E GNL ++ +K R +S
Sbjct: 74 HHPNIINL--LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 131
Query: 128 KALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ L ++ + +G++YL + IHRDL N+ V G KI D
Sbjct: 132 QQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILV-GENYVAKIADF 176
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 2 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 61
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 62 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 120
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 121 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 37.0 bits (84), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALK 131
E ++ ++ NII L V + ITE +G L ++ R+K SV L
Sbjct: 93 FLGEAGIMGQFSHHNIIRLEGVI--SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL +HRDL N+ VN N
Sbjct: 151 GMLRGIAAGMKYLANMN--YVHRDLAARNILVNSN 183
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 3 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 63 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 122 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 3 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 63 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 122 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 30 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 87
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 88 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 144
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 145 KHLHS--AGIIHRDLKPSNIVVKSD 167
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 25 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 84
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 85 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 143
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 144 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
LL+ + NII+L V+ +D + +TE+ G L + + + S + I
Sbjct: 69 LLRYGQHPNIITLKDVY--DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
K + YLH V+HRDL SN+ +GN ++I D
Sbjct: 127 KTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDF 164
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 3 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 62
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 63 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 122 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/160 (25%), Positives = 65/160 (40%), Gaps = 7/160 (4%)
Query: 8 DPSDKDSEPFIETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDP 67
DP++ E E D + Y + E++G+G +V R + G + + +K
Sbjct: 1 DPNEAVREFAKEIDVS--YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTE 58
Query: 68 AMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVS 126
SE ++ + NII L V + + +TE +G L + R +
Sbjct: 59 RQRREFLSEASIMGQFEHPNIIRLEGVVTNS--MPVMILTEFMENGALDSFLRLNDGQFT 116
Query: 127 VKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
V L + I G+ YL E +HRDL N+ VN N
Sbjct: 117 VIQLVGMLRGIASGMRYLA--EMSYVHRDLAARNILVNSN 154
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 7/161 (4%)
Query: 19 ETDPTGRYGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSE 76
E +P + LLGSG VY + + VA V+ D + R+ E
Sbjct: 1 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 60
Query: 77 VRLLKTLAN--KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS 134
V LLK +++ +I L W + + + + +L ++ + + + + +
Sbjct: 61 VVLLKKVSSGFSGVIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 119
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
Q+L+ + H H V+HRD+ N+ ++ N G++K+ D
Sbjct: 120 WQVLEAVR--HCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 83
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 140
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 141 KHLHS--AGIIHRDLKPSNIVVKSD 163
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 37.0 bits (84), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHSA--GIIHRDLKPSNIVVKSD 162
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 19 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 76
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 77 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 133
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 134 KHLHS--AGIIHRDLKPSNIVVKSD 156
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 27 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 84
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 85 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 141
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 142 KHLHSA--GIIHRDLKPSNIVVKSD 164
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 37.0 bits (84), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 30/121 (24%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 56 NQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNL 115
++V ++T + E E ++ L++ ++ L+ V ++ L F E G L
Sbjct: 32 DKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF--EFMEHGCL 89
Query: 116 REYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
+Y + R + + + L + +G+ YL E VIHRDL N V G +K+ D
Sbjct: 90 SDYLRTQRGLFAAETLLGMCLDVCEGMAYLE--EASVIHRDLAARNCLV-GENQVIKVSD 146
Query: 175 L 175
Sbjct: 147 F 147
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 29/100 (29%), Positives = 47/100 (47%), Gaps = 7/100 (7%)
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
LL+ + NII+L V+ +D + +TE+ G L + + + S + I
Sbjct: 69 LLRYGQHPNIITLKDVY--DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTIT 126
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFV---NGNTGQVKIGDL 175
K + YLH V+HRDL SN+ +GN ++I D
Sbjct: 127 KTVEYLHAQ--GVVHRDLKPSNILYVDESGNPESIRICDF 164
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 36.6 bits (83), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 14/154 (9%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPFQNQ-THAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+LH+ +IHRDL SN+ V + +KI D
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD-ATLKILDF 170
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 36.6 bits (83), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 22/55 (40%), Positives = 32/55 (58%), Gaps = 2/55 (3%)
Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K + + L K + I+K L +LH+ + VIHRD+ SNV +N GQVK+ D
Sbjct: 102 KGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKMCDF 154
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 36.6 bits (83), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 22/55 (40%), Positives = 31/55 (56%), Gaps = 2/55 (3%)
Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K + + L K + I+K L +LH+ VIHRD+ SNV +N GQVK+ D
Sbjct: 146 KGQTIPEDILGKIAVSIVKALEHLHSKL-SVIHRDVKPSNVLINA-LGQVKMCDF 198
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 36.2 bits (82), Expect = 0.013, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D + +VA ++ DP+ R E
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREA 63
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 124 DACQALNF--SHQNGIIHRDVKPANIMISA-TNAVKVMDF 160
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 36.2 bits (82), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 41/145 (28%), Positives = 69/145 (47%), Gaps = 13/145 (8%)
Query: 28 RYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
RY L +GSGA V A+D VA ++ R F + +R + E+ L+K + +
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLS-RPF-QNQTHAKRAYRELVLMKCVNH 82
Query: 86 KNIISLHYVWRD----EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGL 141
KNII L V+ E+ + + E+ + + + + H + L Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL---LYQMLCGI 139
Query: 142 NYLHTHEPCVIHRDLNCSNVFVNGN 166
+LH+ +IHRDL SN+ V +
Sbjct: 140 KHLHS--AGIIHRDLKPSNIVVKSD 162
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 36.2 bits (82), Expect = 0.014, Method: Compositional matrix adjust.
Identities = 20/78 (25%), Positives = 37/78 (47%), Gaps = 3/78 (3%)
Query: 98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLN 157
+D + I + G L +K + K ++ ++ L YLH+ + +I+RDL
Sbjct: 76 QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLK 133
Query: 158 CSNVFVNGNTGQVKIGDL 175
N+ ++ N G +KI D
Sbjct: 134 PENILLDKN-GHIKITDF 150
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 36.2 bits (82), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D + +VA ++ DP+ R E
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREA 63
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 124 DACQALNF--SHQNGIIHRDVKPANILISA-TNAVKVVDF 160
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 36.2 bits (82), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 70/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D + +VA ++ DP+ R E
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREA 63
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 124 DACQALNF--SHQNGIIHRDVKPANIMISA-TNAVKVMDF 160
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 36.2 bits (82), Expect = 0.015, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGAVHRDLAARNILINSN 183
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 36.2 bits (82), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 7/148 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSEVRLLKTLAN--KN 87
LLGSG VY + + VA V+ D + R+ EV LLK +++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+I L W + + + + +L ++ + + + + + Q+L+ + H H
Sbjct: 71 VIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRD+ N+ ++ N G++K+ D
Sbjct: 128 NXGVLHRDIKDENILIDLNRGELKLIDF 155
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 36.2 bits (82), Expect = 0.016, Method: Compositional matrix adjust.
Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA---MIERLFSEVRLLKTLAN 85
+NE LG G K+++ +E G ++ ++ D A E F ++ L++
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYL 144
K+++ + V D N L + E G+L Y KK+++ +++ + +KQ+ +++L
Sbjct: 72 KHLVLNYGVCVCGDENIL--VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129
Query: 145 HTHEPCVIHRDLNCSNVFV-------NGNTGQVKIGD 174
E +IH ++ N+ + GN +K+ D
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 35.8 bits (81), Expect = 0.017, Method: Compositional matrix adjust.
Identities = 35/142 (24%), Positives = 57/142 (40%), Gaps = 5/142 (3%)
Query: 26 YGRYNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
Y + E++G+G +V R + G + + +K SE ++ +
Sbjct: 15 YVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEH 74
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALKKWSKQILKGLNYL 144
NII L V + + +TE +G L + R +V L + I G+ YL
Sbjct: 75 PNIIRLEGVVTNS--MPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYL 132
Query: 145 HTHEPCVIHRDLNCSNVFVNGN 166
E +HRDL N+ VN N
Sbjct: 133 A--EMSYVHRDLAARNILVNSN 152
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 35.8 bits (81), Expect = 0.019, Method: Compositional matrix adjust.
Identities = 24/100 (24%), Positives = 50/100 (50%), Gaps = 5/100 (5%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSK 135
E +L + + ++ LHY ++ E + L I + G+L K + + +K +
Sbjct: 80 ERDILADVNHPFVVKLHYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 137
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++ GL++LH+ +I+RDL N+ ++ G +K+ D
Sbjct: 138 ELALGLDHLHSL--GIIYRDLKPENILLD-EEGHIKLTDF 174
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 35.8 bits (81), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 23/74 (31%), Positives = 38/74 (51%), Gaps = 5/74 (6%)
Query: 103 LNFITEVCTSGNLREYRKKHRHV-SVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNV 161
L IT +C L + + V V ++ +++I+KG+ YLH ++H+DL NV
Sbjct: 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK--GILHKDLKSKNV 161
Query: 162 FVNGNTGQVKIGDL 175
F + G+V I D
Sbjct: 162 FY--DNGKVVITDF 173
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 35.8 bits (81), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V A + G VA ++ LR E LF+EV +++ ++N++ ++
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 137
Query: 93 --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
Y+ DE + F+ + + R ++ L +L+ L+ LH
Sbjct: 138 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-----VLQALSVLHAQ--G 190
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
VIHRD+ ++ + + G+VK+ D
Sbjct: 191 VIHRDIKSDSILLT-HDGRVKLSDF 214
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 35.8 bits (81), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 22/74 (29%), Positives = 36/74 (48%), Gaps = 3/74 (4%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L I E + G L E S + + +Q+L G++Y H+ + C HRDL N
Sbjct: 91 LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC--HRDLKLENTL 148
Query: 163 VNGNTG-QVKIGDL 175
++G+ ++KI D
Sbjct: 149 LDGSPAPRLKICDF 162
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 35.8 bits (81), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGFVHRDLAARNILINSN 183
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 35.8 bits (81), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 21/150 (14%)
Query: 30 NELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
+++LG GA V+R ++ G I+V N LR ++ E +LK L +
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNH 66
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----KQILKG 140
KNI+ L + + I E C G+L Y + L + + ++ G
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 141 LNYLHTHEPCVIHRDLNCSNVF-VNGNTGQ 169
+N H E ++HR++ N+ V G GQ
Sbjct: 125 MN--HLRENGIVHRNIKPGNIMRVIGEDGQ 152
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 35.4 bits (80), Expect = 0.021, Method: Compositional matrix adjust.
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V A + G VA ++ LR E LF+EV +++ ++N++ ++
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 83
Query: 93 --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
Y+ DE + F+ + + R ++ L +L+ L+ LH
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-----VLQALSVLHAQ--G 136
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
VIHRD+ ++ + + G+VK+ D
Sbjct: 137 VIHRDIKSDSILLT-HDGRVKLSDF 160
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 35.4 bits (80), Expect = 0.022, Method: Compositional matrix adjust.
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V A + G VA ++ LR E LF+EV +++ ++N++ ++
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 94
Query: 93 --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
Y+ DE + F+ + + R ++ L +L+ L+ LH
Sbjct: 95 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-----VLQALSVLHAQ--G 147
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
VIHRD+ ++ + + G+VK+ D
Sbjct: 148 VIHRDIKSDSILLT-HDGRVKLSDF 171
>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its
Substrate AsfSF2
Length = 381
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 21/159 (13%)
Query: 27 GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
GRY+ + LG G V+ ++D + VA VK + A+ E+RLLK++
Sbjct: 21 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-----DEIRLLKSVR 75
Query: 85 NKN--------IISLHYVWRDEDRNTLN--FITEVCTSGNLREYRKK-HRHVSVKALKKW 133
N + ++ L ++ N + + EV L+ K ++ + + +KK
Sbjct: 76 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 135
Query: 134 SKQILKGLNYLHTHEPC-VIHRDLNCSNVFVNGNTGQVK 171
+Q+L+GL+YLHT C +IH D+ N+ ++ N ++
Sbjct: 136 IQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIR 172
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 81 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 138
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 139 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 171
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 64 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 121
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 122 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 154
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 25/107 (23%), Positives = 52/107 (48%), Gaps = 10/107 (9%)
Query: 71 ERLFSEVRLLKTLANKNIISLH--YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVK 128
E LF+EV +++ ++N++ ++ Y+ DE + F+ + + R ++
Sbjct: 71 ELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAV 130
Query: 129 ALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
L +L+ L+ LH VIHRD+ ++ + + G+VK+ D
Sbjct: 131 CLA-----VLQALSVLHAQ--GVIHRDIKSDSILLT-HDGRVKLSDF 169
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 35.4 bits (80), Expect = 0.023, Method: Compositional matrix adjust.
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 14/145 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V A + G VA ++ LR E LF+EV +++ ++N++ ++
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 87
Query: 93 --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
Y+ DE + F+ + + R ++ L +L+ L+ LH
Sbjct: 88 NSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA-----VLQALSVLHAQ--G 140
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
VIHRD+ ++ + + G+VK+ D
Sbjct: 141 VIHRDIKSDSILLT-HDGRVKLSDF 164
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 35.4 bits (80), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 14/145 (9%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
+G G+ V A + G VA ++ LR E LF+EV +++ ++N++ ++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRR----ELLFNEVVIMRDYQHENVVEMY 214
Query: 93 --YVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPC 150
Y+ DE L + E G L + H ++ + + +L+ L+ LH
Sbjct: 215 NSYLVGDE----LWVVMEFLEGGALTDI-VTHTRMNEEQIAAVCLAVLQALSVLHAQ--G 267
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
VIHRD+ ++ + + G+VK+ D
Sbjct: 268 VIHRDIKSDSILLT-HDGRVKLSDF 291
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 35.4 bits (80), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 7/148 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSEVRLLKTLAN--KN 87
LLGSG VY + + VA V+ D + R+ EV LLK +++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+I L W + + + + +L ++ + + + + + Q+L+ + H H
Sbjct: 71 VIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRD+ N+ ++ N G++K+ D
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDF 155
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 35.4 bits (80), Expect = 0.024, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEXMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 35.4 bits (80), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 34/148 (22%), Positives = 66/148 (44%), Gaps = 7/148 (4%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIE--RLFSEVRLLKTLAN--KN 87
LLGSG VY + + VA V+ D + R+ EV LLK +++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
+I L W + + + + +L ++ + + + + + Q+L+ + H H
Sbjct: 71 VIRL-LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR--HCH 127
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
V+HRD+ N+ ++ N G++K+ D
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDF 155
>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide
pdb|1WAK|A Chain A, X-Ray Structure Of Srpk1
Length = 397
Score = 35.4 bits (80), Expect = 0.025, Method: Compositional matrix adjust.
Identities = 41/159 (25%), Positives = 76/159 (47%), Gaps = 21/159 (13%)
Query: 27 GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLA 84
GRY+ + LG G V+ ++D + VA VK + A+ E+RLLK++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETAL-----DEIRLLKSVR 91
Query: 85 NKN--------IISLHYVWRDEDRNTLN--FITEVCTSGNLREYRKK-HRHVSVKALKKW 133
N + ++ L ++ N + + EV L+ K ++ + + +KK
Sbjct: 92 NSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 134 SKQILKGLNYLHTHEPC-VIHRDLNCSNVFVNGNTGQVK 171
+Q+L+GL+YLHT C +IH D+ N+ ++ N ++
Sbjct: 152 IQQVLQGLDYLHTK--CRIIHTDIKPENILLSVNEQYIR 188
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 35.4 bits (80), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 22/55 (40%), Positives = 31/55 (56%), Gaps = 2/55 (3%)
Query: 121 KHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
K + + L K + I+K L +LH+ + VIHRD+ SNV +N GQVK D
Sbjct: 129 KGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINA-LGQVKXCDF 181
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 35.4 bits (80), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 64 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 121
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 122 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 154
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.026, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 91 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 148
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 149 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 181
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 35.4 bits (80), Expect = 0.027, Method: Compositional matrix adjust.
Identities = 25/85 (29%), Positives = 40/85 (47%), Gaps = 15/85 (17%)
Query: 103 LNFITEVCTSGNLREYRKKHRH------------VSVKALKKWSKQILKGLNYLHTHEPC 150
L I E C GNL Y + R+ ++++ L +S Q+ KG+ +L + +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-- 164
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+ ++ VKI D
Sbjct: 165 XIHRDLAARNILLS-EKNVVKIXDF 188
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 35.4 bits (80), Expect = 0.028, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKH-RHVSVKALK 131
E ++ + NII L V + +TE +G+L + +KH +V L
Sbjct: 93 FLGEASIMGQFDHPNIIRLEGVVTKS--KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 151 GMLRGIASGMKYLS--DMGYVHRDLAARNILINSN 183
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 35.0 bits (79), Expect = 0.030, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D +VA ++ DP+ R E
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREA 63
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 64 QNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 124 DACQALNF--SHQNGIIHRDVKPANIMISA-TNAVKVMDF 160
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 35.0 bits (79), Expect = 0.031, Method: Compositional matrix adjust.
Identities = 38/150 (25%), Positives = 64/150 (42%), Gaps = 21/150 (14%)
Query: 30 NELLGSGAVKKVYRAFDQEEG----IEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN 85
+++LG GA V+R ++ G I+V N LR ++ E +LK L +
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRP-------VDVQMREFEVLKKLNH 66
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWS-----KQILKG 140
KNI+ L + + I E C G+L Y + L + + ++ G
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 141 LNYLHTHEPCVIHRDLNCSNVF-VNGNTGQ 169
+N H E ++HR++ N+ V G GQ
Sbjct: 125 MN--HLRENGIVHRNIKPGNIMRVIGEDGQ 152
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 35.0 bits (79), Expect = 0.033, Method: Compositional matrix adjust.
Identities = 26/95 (27%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALK 131
SE ++ + N+I L V + ITE +G+L + R+ +V L
Sbjct: 81 FLSEASIMGQFDHPNVIHLEGVVTKS--TPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 138
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL +HRDL N+ VN N
Sbjct: 139 GMLRGIAAGMKYLADMN--YVHRDLAARNILVNSN 171
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 35.0 bits (79), Expect = 0.034, Method: Compositional matrix adjust.
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G KVY+ +G VA ++K + +EV ++ ++N++ L
Sbjct: 45 ILGRGGFGKVYKG-RLADGTLVAVKRLKEERXQGGELQFQ---TEVEMISMAVHRNLLRL 100
Query: 92 HYVWRDEDRNTL--NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-E 148
L ++ + LRE + + ++ + +GL YLH H +
Sbjct: 101 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 160
Query: 149 PCVIHRDLNCSNVFVN-------GNTGQVKIGD 174
P +IHRD+ +N+ ++ G+ G K+ D
Sbjct: 161 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 35.0 bits (79), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 35/157 (22%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 29 YNELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPA---MIERLFSEVRLLKTLAN 85
+NE LG G K+++ +E G ++ ++ D A E F ++ L++
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 86 KNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH-VSVKALKKWSKQILKGLNYL 144
K+++ + V D N L + E G+L Y KK+++ +++ + +KQ+ +++L
Sbjct: 72 KHLVLNYGVCFCGDENIL--VQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWAMHFL 129
Query: 145 HTHEPCVIHRDLNCSNVFV-------NGNTGQVKIGD 174
E +IH ++ N+ + GN +K+ D
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 35.0 bits (79), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 40/95 (42%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALK 131
SE ++ + NII L V + ITE +G+L + RK +V L
Sbjct: 77 FLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 134
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL +HRDL N+ VN N
Sbjct: 135 GMLRGIGSGMKYLSDMS--AVHRDLAARNILVNSN 167
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 34.7 bits (78), Expect = 0.038, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
LL+ + NII+L V+ +D + +TE+ G L + + + S + I
Sbjct: 74 LLRYGQHPNIITLKDVY--DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
K + YLH+ V+HRDL SN+ +G
Sbjct: 132 KTVEYLHSQ--GVVHRDLKPSNILYVDESG 159
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 34.7 bits (78), Expect = 0.039, Method: Compositional matrix adjust.
Identities = 26/90 (28%), Positives = 43/90 (47%), Gaps = 4/90 (4%)
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
LL+ + NII+L V+ +D + +TE+ G L + + + S + I
Sbjct: 74 LLRYGQHPNIITLKDVY--DDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIG 131
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTG 168
K + YLH+ V+HRDL SN+ +G
Sbjct: 132 KTVEYLHSQ--GVVHRDLKPSNILYVDESG 159
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 34.7 bits (78), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 31/140 (22%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
E +GSG V++ + +G A + K L D+ + +++ L + + ++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 73
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSV---KALKKWSKQILKGLNYL 144
+ W ++D + E C G+L + + +R +S LK Q+ +GL Y+
Sbjct: 74 VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 145 HTHEPCVIHRDLNCSNVFVN 164
H+ ++H D+ SN+F++
Sbjct: 132 HSM--SLVHMDIKPSNIFIS 149
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 34.7 bits (78), Expect = 0.046, Method: Compositional matrix adjust.
Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 17/146 (11%)
Query: 30 NELLGSGAVKK-VYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI 88
++LG GA VYR + V + +F D EV+LL+ ++++
Sbjct: 29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---------REVQLLRE-SDEHP 78
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHT 146
+ Y ++DR E+C + L+EY +K H+ ++ + +Q GL +LH+
Sbjct: 79 NVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHS 136
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKI 172
++HRDL N+ ++ KI
Sbjct: 137 LN--IVHRDLKPHNILISMPNAHGKI 160
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 34.7 bits (78), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ LHY ++ E + L I + G+L K + + +K + ++ L++LH+
Sbjct: 88 IVKLHYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL 145
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+I+RDL N+ ++ G +K+ D
Sbjct: 146 --GIIYRDLKPENILLD-EEGHIKLTDF 170
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 34.7 bits (78), Expect = 0.047, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D +VA ++ DP+ R E
Sbjct: 22 TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREA 80
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 81 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 140
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 141 DACQALNF--SHQNGIIHRDVKPANIMISA-TNAVKVMDF 177
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 34.3 bits (77), Expect = 0.050, Method: Compositional matrix adjust.
Identities = 31/140 (22%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
E +GSG V++ + +G A + K L D+ + +++ L + + ++
Sbjct: 15 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 71
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSV---KALKKWSKQILKGLNYL 144
+ W ++D + E C G+L + + +R +S LK Q+ +GL Y+
Sbjct: 72 VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 145 HTHEPCVIHRDLNCSNVFVN 164
H+ ++H D+ SN+F++
Sbjct: 130 HSM--SLVHMDIKPSNIFIS 147
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 34.3 bits (77), Expect = 0.052, Method: Compositional matrix adjust.
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 32 LLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISL 91
+LG G KVY+ +G VA ++K + +EV ++ ++N++ L
Sbjct: 37 ILGRGGFGKVYKG-RLADGXLVAVKRLKEERTQGGELQFQ---TEVEMISMAVHRNLLRL 92
Query: 92 HYVWRDEDRNTL--NFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH-E 148
L ++ + LRE + + ++ + +GL YLH H +
Sbjct: 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCD 152
Query: 149 PCVIHRDLNCSNVFVN-------GNTGQVKIGD 174
P +IHRD+ +N+ ++ G+ G K+ D
Sbjct: 153 PKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 34.3 bits (77), Expect = 0.053, Method: Compositional matrix adjust.
Identities = 38/160 (23%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 20 TDPTGRYGRY--NELLGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEV 77
T P+ RY E+LG G + +V+ A D +VA ++ DP+ R E
Sbjct: 5 TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRA-DLARDPSFYLRFRREA 63
Query: 78 RLLKTLANKNIISLHYVWRDE-DRNTLNFIT-EVCTSGNLREYRKKHRHVSVKALKKWSK 135
+ L + I++++ E L +I E LR+ ++ K +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ LN+ +H+ +IHRD+ +N+ ++ T VK+ D
Sbjct: 124 DACQALNF--SHQNGIIHRDVKPANIMISA-TNAVKVMDF 160
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 34.3 bits (77), Expect = 0.058, Method: Compositional matrix adjust.
Identities = 31/140 (22%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
E +GSG V++ + +G A + K L D+ + +++ L + + ++
Sbjct: 15 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 71
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSV---KALKKWSKQILKGLNYL 144
+ W ++D + E C G+L + + +R +S LK Q+ +GL Y+
Sbjct: 72 VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 129
Query: 145 HTHEPCVIHRDLNCSNVFVN 164
H+ ++H D+ SN+F++
Sbjct: 130 HSM--SLVHMDIKPSNIFIS 147
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 34.3 bits (77), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 31/140 (22%), Positives = 65/140 (46%), Gaps = 13/140 (9%)
Query: 31 ELLGSGAVKKVYRAFDQEEGIEVAWNQVK--LRTFCDDPAMIERLFSEVRLLKTLANKNI 88
E +GSG V++ + +G A + K L D+ + +++ L + + ++
Sbjct: 13 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ---HSHV 69
Query: 89 ISLHYVWRDEDRNTLNFITEVCTSGNLRE-YRKKHRHVSV---KALKKWSKQILKGLNYL 144
+ W ++D + E C G+L + + +R +S LK Q+ +GL Y+
Sbjct: 70 VRYFSAWAEDDHMLIQ--NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 127
Query: 145 HTHEPCVIHRDLNCSNVFVN 164
H+ ++H D+ SN+F++
Sbjct: 128 HSM--SLVHMDIKPSNIFIS 145
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 34.3 bits (77), Expect = 0.061, Method: Compositional matrix adjust.
Identities = 28/85 (32%), Positives = 39/85 (45%), Gaps = 15/85 (17%)
Query: 103 LNFITEVCTSGNLREY--RKKHRHVSVKALKK----------WSKQILKGLNYLHTHEPC 150
L I E C GNL Y K++ V K L K +S Q+ KG+ +L + +
Sbjct: 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK-- 164
Query: 151 VIHRDLNCSNVFVNGNTGQVKIGDL 175
IHRDL N+ ++ VKI D
Sbjct: 165 XIHRDLAARNILLS-EKNVVKICDF 188
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 33.9 bits (76), Expect = 0.065, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALK 131
SE ++ + NII L V + ITE +G+L + RK +V L
Sbjct: 56 FLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 113
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ VN N
Sbjct: 114 GMLRGIGSGMKYLS--DMSYVHRDLAARNILVNSN 146
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 33.9 bits (76), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLAN-KNIISL 91
LG G V + + G E A +K R D + E+ +L+ + +I+L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA--EILHEIAVLELAKSCPRVINL 94
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREY--RKKHRHVSVKALKKWSKQILKGLNYLHTHEP 149
H V+ E+ + + I E G + + VS + + KQIL+G+ YLH +
Sbjct: 95 HEVY--ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN- 151
Query: 150 CVIHRDLNCSNVFVNG--NTGQVKIGDL 175
++H DL N+ ++ G +KI D
Sbjct: 152 -IVHLDLKPQNILLSSIYPLGDIKIVDF 178
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 33.9 bits (76), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ LHY ++ E + L I + G+L K + + +K + ++ L++LH+
Sbjct: 88 IVKLHYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS- 144
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+I+RDL N+ ++ G +K+ D
Sbjct: 145 -LGIIYRDLKPENILLD-EEGHIKLTDF 170
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 33.9 bits (76), Expect = 0.066, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L ITE C GNL Y + R+
Sbjct: 68 LMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 183
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 33.9 bits (76), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 22/88 (25%), Positives = 44/88 (50%), Gaps = 5/88 (5%)
Query: 88 IISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTH 147
I+ LHY ++ E + L I + G+L K + + +K + ++ L++LH+
Sbjct: 89 IVKLHYAFQTEGK--LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS- 145
Query: 148 EPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+I+RDL N+ ++ G +K+ D
Sbjct: 146 -LGIIYRDLKPENILLD-EEGHIKLTDF 171
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 33.9 bits (76), Expect = 0.067, Method: Compositional matrix adjust.
Identities = 25/89 (28%), Positives = 40/89 (44%), Gaps = 17/89 (19%)
Query: 101 NTLNFITEVCTSGNLREYRKKHRH--------------VSVKALKKWSKQILKGLNYLHT 146
L I E C GNL Y + R+ ++++ L +S Q+ KG+ +L +
Sbjct: 107 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLAS 166
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ IHRDL N+ ++ VKI D
Sbjct: 167 RK--XIHRDLAARNILLS-EKNVVKICDF 192
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 33.9 bits (76), Expect = 0.069, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L ITE C GNL Y + R+
Sbjct: 68 LMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 183
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 33.9 bits (76), Expect = 0.071, Method: Compositional matrix adjust.
Identities = 28/95 (29%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREY-RKKHRHVSVKALK 131
SE ++ + NII L V + ITE +G+L + RK +V L
Sbjct: 62 FLSEASIMGQFDHPNIIHLEGVV--TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLV 119
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ VN N
Sbjct: 120 GMLRGIGSGMKYLS--DMSYVHRDLAARNILVNSN 152
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 33.9 bits (76), Expect = 0.076, Method: Compositional matrix adjust.
Identities = 26/89 (29%), Positives = 41/89 (46%), Gaps = 19/89 (21%)
Query: 103 LNFITEVCTSGNLREYRKKHRH----------------VSVKALKKWSKQILKGLNYLHT 146
L ITE C GNL Y + R+ ++++ L +S Q+ KG+ +L +
Sbjct: 98 LMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 157
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
+ IHRDL N+ ++ VKI D
Sbjct: 158 RK--CIHRDLAARNILLS-EKNVVKICDF 183
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 33.5 bits (75), Expect = 0.095, Method: Compositional matrix adjust.
Identities = 35/160 (21%), Positives = 69/160 (43%), Gaps = 27/160 (16%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNIISLH 92
LG G V+ A ++ + A +++L + E++ EV+ L L + I+
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRL---PNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 93 YVWRDED----------RNTLNFITEVCTSGNLREY-------RKKHRHVSVKALKKWSK 135
W +++ + L ++C NL+++ ++ R V +
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFL---- 125
Query: 136 QILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
QI + + +LH+ ++HRDL SN+F + VK+GD
Sbjct: 126 QIAEAVEFLHSK--GLMHRDLKPSNIFFTMD-DVVKVGDF 162
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 33.5 bits (75), Expect = 0.10, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 3/74 (4%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L + E + G L E S + + +Q++ G++Y H + V HRDL N
Sbjct: 90 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ--VAHRDLKLENTL 147
Query: 163 VNGNTG-QVKIGDL 175
++G+ ++KI D
Sbjct: 148 LDGSPAPRLKIADF 161
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 33.1 bits (74), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 30/104 (28%), Positives = 46/104 (44%), Gaps = 17/104 (16%)
Query: 76 EVRLLKTLANKNIISLHYVWRDEDRNT-----LNFITEVCTSGNLREYRKKHRHVSVKAL 130
EV L + ++NI+ E R T L IT G+L ++ K + VS L
Sbjct: 68 EVYSLPGMKHENILQFIGA---EKRGTSVDVDLWLITAFHEKGSLSDFLKANV-VSWNEL 123
Query: 131 KKWSKQILKGLNYLHT--------HEPCVIHRDLNCSNVFVNGN 166
++ + +GL YLH H+P + HRD+ NV + N
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN 167
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 32.7 bits (73), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 3/74 (4%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L + E + G L E S + + +Q++ G++Y H + C HRDL N
Sbjct: 90 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC--HRDLKLENTL 147
Query: 163 VNGNTG-QVKIGDL 175
++G+ ++KI D
Sbjct: 148 LDGSPAPRLKICDF 161
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 32.7 bits (73), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 20/74 (27%), Positives = 35/74 (47%), Gaps = 3/74 (4%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L + E + G L E S + + +Q++ G++Y H + C HRDL N
Sbjct: 89 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC--HRDLKLENTL 146
Query: 163 VNGNTG-QVKIGDL 175
++G+ ++KI D
Sbjct: 147 LDGSPAPRLKICDF 160
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 32.7 bits (73), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 25/95 (26%), Positives = 41/95 (43%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALK 131
E ++ + NII L V + +TE +G+L + KK+ +V L
Sbjct: 70 FLGEASIMGQFDHPNIIHLEGVVTKS--KPVMIVTEYMENGSLDTFLKKNDGQFTVIQLV 127
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ +N N
Sbjct: 128 GMLRGISAGMKYLS--DMGYVHRDLAARNILINSN 160
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 32.7 bits (73), Expect = 0.17, Method: Compositional matrix adjust.
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 20/119 (16%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 78 LMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT 136
Query: 125 --------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 192
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 32.3 bits (72), Expect = 0.19, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 192
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 32.3 bits (72), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 114 LMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 172
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 229
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 32.3 bits (72), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 79 LMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKE 137
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 138 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 194
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 32.3 bits (72), Expect = 0.20, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 192
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 32.3 bits (72), Expect = 0.21, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 77 LMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 135
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 136 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 192
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 32.0 bits (71), Expect = 0.24, Method: Compositional matrix adjust.
Identities = 31/120 (25%), Positives = 55/120 (45%), Gaps = 21/120 (17%)
Query: 73 LFSEVRLLKTLANK-NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRH------- 124
L SE+++L + + N+++L + L I E C GNL Y + R+
Sbjct: 68 LMSELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV 126
Query: 125 ---------VSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
++++ L +S Q+ KG+ +L + + IHRDL N+ ++ VKI D
Sbjct: 127 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS-EKNVVKICDF 183
>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
pdb|3ZUU|B Chain B, The Structure Of Ost1 (D160a, S175d) Kinase In Complex
With Gold
Length = 362
Score = 32.0 bits (71), Expect = 0.30, Method: Compositional matrix adjust.
Identities = 17/66 (25%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L + E + G L E S + + +Q++ G++Y H + C HRDL N
Sbjct: 90 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC--HRDLKLENTL 147
Query: 163 VNGNTG 168
++G+
Sbjct: 148 LDGSPA 153
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 32.0 bits (71), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 17/66 (25%), Positives = 30/66 (45%), Gaps = 2/66 (3%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVF 162
L + E + G L E S + + +Q++ G++Y H + C HRDL N
Sbjct: 90 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVC--HRDLKLENTL 147
Query: 163 VNGNTG 168
++G+
Sbjct: 148 LDGSPA 153
>pdb|1ZGD|A Chain A, Chalcone Reductase Complexed With Nadp+ At 1.7 Angstrom
Resolution
pdb|1ZGD|B Chain B, Chalcone Reductase Complexed With Nadp+ At 1.7 Angstrom
Resolution
Length = 312
Score = 32.0 bits (71), Expect = 0.31, Method: Compositional matrix adjust.
Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 1/42 (2%)
Query: 37 AVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVR 78
+V V A +Q E + +AW Q KLR FC+ ++ FS VR
Sbjct: 178 SVATVLPAVNQVE-MNLAWQQKKLREFCNAHGIVLTAFSPVR 218
>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The
Inhibitor Apigenin
Length = 326
Score = 31.6 bits (70), Expect = 0.37, Method: Compositional matrix adjust.
Identities = 21/96 (21%), Positives = 48/96 (50%), Gaps = 5/96 (5%)
Query: 79 LLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQIL 138
L + NI+ L + RD+ T + I E N +++ + ++ ++ + ++L
Sbjct: 79 LQNLMGGPNIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELL 135
Query: 139 KGLNYLHTHEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
K L+Y H+ ++HRD+ NV ++ ++++ D
Sbjct: 136 KALDYCHSQ--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1
pdb|3OP5|B Chain B, Human Vaccinia-Related Kinase 1
pdb|3OP5|C Chain C, Human Vaccinia-Related Kinase 1
pdb|3OP5|D Chain D, Human Vaccinia-Related Kinase 1
Length = 364
Score = 31.2 bits (69), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 3/58 (5%)
Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGD 174
Y + S K + + S +IL L Y+H HE +H D+ SN+ +N N QV + D
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 30.8 bits (68), Expect = 0.53, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 18/79 (22%)
Query: 98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK----KWSKQI------LKGLNYLHTH 147
++RN + I + +GNL+ RH+ L W +++ +GL+YLHT
Sbjct: 105 DERNEMILIYKYMENGNLK------RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 148 EPCVIHRDLNCSNVFVNGN 166
+IHRD+ N+ ++ N
Sbjct: 159 --AIIHRDVKSINILLDEN 175
>pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1
pdb|2KUL|A Chain A, Solution Structure Of Human Vaccinia Related Kinase
1(Vrk1)
Length = 368
Score = 30.8 bits (68), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 3/58 (5%)
Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGD 174
Y + S K + + S +IL L Y+H HE +H D+ SN+ +N N QV + D
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific
Kinase 2 (Srpk2) Bound To Purvalanol B
Length = 389
Score = 30.8 bits (68), Expect = 0.56, Method: Compositional matrix adjust.
Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 21/159 (13%)
Query: 27 GRYNEL--LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTL- 83
GRY+ + LG G V+ +D + VA VK + A+ E++LLK +
Sbjct: 31 GRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETAL-----DEIKLLKCVR 85
Query: 84 ------ANKN-IISLHYVWRDEDRNTLN--FITEVCTSGNLREYRKK-HRHVSVKALKKW 133
NK+ ++ L ++ N ++ + EV L+ K ++ + V+ +K
Sbjct: 86 ESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSI 145
Query: 134 SKQILKGLNYLHTHEPC-VIHRDLNCSNVFVNGNTGQVK 171
+Q+L+GL+YLH+ C +IH D+ N+ + + V+
Sbjct: 146 IRQVLQGLDYLHSK--CKIIHTDIKPENILMCVDDAYVR 182
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 30.8 bits (68), Expect = 0.57, Method: Compositional matrix adjust.
Identities = 22/79 (27%), Positives = 39/79 (49%), Gaps = 18/79 (22%)
Query: 98 EDRNTLNFITEVCTSGNLREYRKKHRHVSVKALK----KWSKQI------LKGLNYLHTH 147
++RN + I + +GNL+ RH+ L W +++ +GL+YLHT
Sbjct: 105 DERNEMILIYKYMENGNLK------RHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR 158
Query: 148 EPCVIHRDLNCSNVFVNGN 166
+IHRD+ N+ ++ N
Sbjct: 159 --AIIHRDVKSINILLDEN 175
>pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1
Length = 361
Score = 30.8 bits (68), Expect = 0.58, Method: Compositional matrix adjust.
Identities = 20/58 (34%), Positives = 30/58 (51%), Gaps = 3/58 (5%)
Query: 118 YRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVN-GNTGQVKIGD 174
Y + S K + + S +IL L Y+H HE +H D+ SN+ +N N QV + D
Sbjct: 142 YEANAKRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYKNPDQVYLVD 197
>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVJ|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVK|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVL|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVM|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|2PVN|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine
Derivatives As Potent Inhibitors Of Protein Kinase Ck2
pdb|3BE9|A Chain A, Structure-Based Design And Synthesis Of Novel Macrocyclic
Pyrazolo[1,5-A] [1,3,5]triazine Compounds As Potent
Inhibitors Of Protein Kinase Ck2 And Their Anticancer
Activities
Length = 352
Score = 30.8 bits (68), Expect = 0.64, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 108 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 164
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 165 Q--GIMHRDVKPHNVMIDHELRKLRLID 190
>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro-
AnthraquinoneCK2 KINASE COMPLEX
pdb|4DGO|A Chain A, Crystal Structure Of Maize Ck2 In Complex With Tyrphostin
Ag99
Length = 325
Score = 30.8 bits (68), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 87 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 144 Q--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor
Length = 335
Score = 30.8 bits (68), Expect = 0.68, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 89 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 145
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 146 Q--GIMHRDVKPHNVMIDHELRKLRLID 171
>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc
pdb|3FL5|A Chain A, Protein Kinase Ck2 In Complex With The Inhibitor
Quinalizarin
pdb|3PZH|A Chain A, Crystal Structure Of Maize Ck2 Alpha In Complex With
Emodin At 1.92 A Resolution
Length = 332
Score = 30.4 bits (67), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 88 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 144
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 145 Q--GIMHRDVKPHNVMIDHELRKLRLID 170
>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase
Ck2 (Alpha-Subunit) And Mg-Amppnp
pdb|1DAY|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase
Ck2 (Alpha-Subunit) And Mg-Gmppnp
pdb|1M2Q|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro-Xanten-9-
OneCK2 KINASE COMPLEX
pdb|1M2R|A Chain A, Crystal Structure Of 5,8-Di-Amino-1,4-Di-Hydroxy-
AnthraquinoneCK2 KINASE COMPLEX
pdb|3KXM|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor K74
pdb|3KXN|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor Tetraiodobenzimidazole (K88)
Length = 327
Score = 30.4 bits (67), Expect = 0.69, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 87 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 144 Q--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor
3,4,5,6,7-Pentabromo-1h-Indazole (K64)
pdb|3KXH|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Inhibitor
(2-Dymethylammino-4,5,6,7-Tetrabromobenzoimidazol-1yl-
Acetic Acid (K66)
Length = 327
Score = 30.4 bits (67), Expect = 0.70, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 87 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 144 Q--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex
With The Inhibitor
4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68)
Length = 331
Score = 30.4 bits (67), Expect = 0.71, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 87 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 144 Q--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The
Inhibitor Luteolin
Length = 326
Score = 30.4 bits (67), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 87 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 143
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 144 Q--GIMHRDVKPHNVMIDHELRKLRLID 169
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 30.4 bits (67), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 23/95 (24%), Positives = 39/95 (41%), Gaps = 5/95 (5%)
Query: 73 LFSEVRLLKTLANKNIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHR-HVSVKALK 131
E ++ + N++ L V + + E +G L + +KH +V L
Sbjct: 91 FLCEASIMGQFDHPNVVHLEGVV--TRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLV 148
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN 166
+ I G+ YL + +HRDL N+ VN N
Sbjct: 149 GMLRGIAAGMRYLA--DMGYVHRDLAARNILVNSN 181
>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|B Chain B, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|C Chain C, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1DS5|D Chain D, Dimeric Crystal Structure Of The Alpha Subunit In Complex
With Two Beta Peptides Mimicking The Architecture Of The
Tetrameric Protein Kinase Ck2 Holoenzyme.
pdb|1F0Q|A Chain A, Crystal Structure Of The Alpha Subunit Of Protein Kinase
Ck2 In Complex With The Nucleotide Competitive Inhibitor
Emodin
pdb|1J91|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Atp-Competitive Inhibitor 4,5,6,7-
Tetrabromobenzotriazole
pdb|1J91|B Chain B, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In
Complex With The Atp-Competitive Inhibitor 4,5,6,7-
Tetrabromobenzotriazole
pdb|1JAM|A Chain A, Crystal Structure Of Apo-Form Of Z. Mays Ck2 Protein
Kinase Alpha Subunit
pdb|1LP4|A Chain A, Crystal Structure Of A Binary Complex Of The Catalytic
Subunit Of Protein Kinase Ck2 With Mg-Amppnp
pdb|1LPU|A Chain A, Low Temperature Crystal Structure Of The Apo-Form Of The
Catalytic Subunit Of Protein Kinase Ck2 From Zea Mays
pdb|1LR4|A Chain A, Room Temperature Crystal Structure Of The Apo-Form Of The
Catalytic Subunit Of Protein Kinase Ck2 From Zea Mays
pdb|1OM1|A Chain A, Crystal Structure Of Maize Ck2 Alpha In Complex With Iqa
pdb|1ZOE|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives Inhibitors
pdb|1ZOG|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives
pdb|1ZOH|A Chain A, Crystal Structure Of Protein Kinase Ck2 In Complex With
Tbb- Derivatives Inhibitors
pdb|2OXD|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole K17, K22 And K32 Inhibitors
pdb|2OXX|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|2OXY|A Chain A, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|2OXY|B Chain B, Protein Kinase Ck2 In Complex With
Tetrabromobenzoimidazole Derivatives K17, K22 And K32
pdb|3PWD|A Chain A, Crystal Structure Of Maize Ck2 In Complex With Nbc (Z1)
Length = 332
Score = 30.4 bits (67), Expect = 0.72, Method: Compositional matrix adjust.
Identities = 20/88 (22%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NI+ L + RD+ T + I E N +++ + ++ ++ + ++LK L+Y H+
Sbjct: 88 NIVKLLDIVRDQHSKTPSLIFEYV---NNTDFKVLYPTLTDYDIRYYIYELLKALDYCHS 144
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 145 Q--GIMHRDVKPHNVMIDHELRKLRLID 170
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 30.0 bits (66), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 21/77 (27%), Positives = 35/77 (45%), Gaps = 10/77 (12%)
Query: 103 LNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT---------HEPCVIH 153
L IT G+L +Y K + ++ L ++ + +GL+YLH H+P + H
Sbjct: 88 LWLITAFHDKGSLTDYLKGNI-ITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAH 146
Query: 154 RDLNCSNVFVNGNTGQV 170
RD NV + + V
Sbjct: 147 RDFKSKNVLLKSDLTAV 163
>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 29.6 bits (65), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 20/76 (26%), Positives = 38/76 (50%), Gaps = 15/76 (19%)
Query: 100 RNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCVIHRDLNCS 159
++ +FITE G L+E + + + Q+L+ + H H V+HRD+
Sbjct: 142 QDLFDFITE---RGALQE----------ELARSFFWQVLEAVR--HCHNCGVLHRDIKDE 186
Query: 160 NVFVNGNTGQVKIGDL 175
N+ ++ N G++K+ D
Sbjct: 187 NILIDLNRGELKLIDF 202
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 29.6 bits (65), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 12/45 (26%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 132 KWSKQILKGLNYLHTHEPCVIHRDLNCSNVFVNGN-TGQVKIGDL 175
K++ + +G+ +LHT EP + LN +V ++ + T ++ + D+
Sbjct: 115 KFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV 159
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 29.3 bits (64), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 34/144 (23%), Positives = 60/144 (41%), Gaps = 8/144 (5%)
Query: 33 LGSGAVKKVYRAFDQEEGIEVAWNQVKLRTFCDDPAMIERLFSEVRLLKTLANKNI-ISL 91
LG G+ +V++ +E+G A + + F P R +EV + + + L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 92 HYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHTHEPCV 151
W E+ L TE+C G + + S+ + W L H H +
Sbjct: 123 EQAW--EEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGL 178
Query: 152 IHRDLNCSNVFVNGNTGQVKIGDL 175
+H D+ +N+F+ G G+ K+GD
Sbjct: 179 VHLDVKPANIFL-GPRGRCKLGDF 201
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 28.5 bits (62), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 12/31 (38%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
H H+ +I+RDL N+ +N + G VK+ D
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDF 165
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 28.5 bits (62), Expect = 3.2, Method: Compositional matrix adjust.
Identities = 12/31 (38%), Positives = 19/31 (61%), Gaps = 1/31 (3%)
Query: 145 HTHEPCVIHRDLNCSNVFVNGNTGQVKIGDL 175
H H+ +I+RDL N+ +N + G VK+ D
Sbjct: 136 HLHQKGIIYRDLKPENIMLN-HQGHVKLTDF 165
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 27.7 bits (60), Expect = 5.6, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 2/33 (6%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT 167
+QI G+ +LH+ + +IHRDL N+ V+ ++
Sbjct: 140 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSS 170
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 27.7 bits (60), Expect = 5.7, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 2/33 (6%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT 167
+QI G+ +LH+ + +IHRDL N+ V+ ++
Sbjct: 140 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSS 170
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 27.3 bits (59), Expect = 6.6, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 2/33 (6%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT 167
+QI G+ +LH+ + +IHRDL N+ V+ ++
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSS 152
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 27.3 bits (59), Expect = 6.7, Method: Compositional matrix adjust.
Identities = 12/33 (36%), Positives = 22/33 (66%), Gaps = 2/33 (6%)
Query: 135 KQILKGLNYLHTHEPCVIHRDLNCSNVFVNGNT 167
+QI G+ +LH+ + +IHRDL N+ V+ ++
Sbjct: 122 RQIASGVAHLHSLK--IIHRDLKPQNILVSTSS 152
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 27.3 bits (59), Expect = 7.2, Method: Compositional matrix adjust.
Identities = 19/88 (21%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NII L +D T + E N ++++ ++ ++ ++ + ++LK L+Y H+
Sbjct: 94 NIIKLIDTVKDPVSKTPALVFEYI---NNTDFKQLYQILTDFDIRFYMYELLKALDYCHS 150
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 151 --KGIMHRDVKPHNVMIDHQQKKLRLID 176
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 26.9 bits (58), Expect = 7.9, Method: Compositional matrix adjust.
Identities = 19/88 (21%), Positives = 45/88 (51%), Gaps = 5/88 (5%)
Query: 87 NIISLHYVWRDEDRNTLNFITEVCTSGNLREYRKKHRHVSVKALKKWSKQILKGLNYLHT 146
NII L +D T + E N ++++ ++ ++ ++ + ++LK L+Y H+
Sbjct: 99 NIIKLIDTVKDPVSKTPALVFEYI---NNTDFKQLYQILTDFDIRFYMYELLKALDYCHS 155
Query: 147 HEPCVIHRDLNCSNVFVNGNTGQVKIGD 174
++HRD+ NV ++ ++++ D
Sbjct: 156 --KGIMHRDVKPHNVMIDHQQKKLRLID 181
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.321 0.136 0.422
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 6,088,554
Number of Sequences: 62578
Number of extensions: 226317
Number of successful extensions: 1828
Number of sequences better than 100.0: 732
Number of HSP's better than 100.0 without gapping: 151
Number of HSP's successfully gapped in prelim test: 581
Number of HSP's that attempted gapping in prelim test: 1062
Number of HSP's gapped (non-prelim): 735
length of query: 219
length of database: 14,973,337
effective HSP length: 95
effective length of query: 124
effective length of database: 9,028,427
effective search space: 1119524948
effective search space used: 1119524948
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 49 (23.5 bits)